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ABSTRACT

AN EXPLORATION OF THE EFFECTS OF AN EARLY POSTPARTUM
INTRAVENOUS INFUSION WITH CARNOSIC ACID ON PHYSIOLOGICAL
RESPONSES OF TRANSITION DAIRY COWS

TAINARA MICHELOTTI

2021

The transition period is commonly defined as the last 3 wk before parturition to 3 wk
after parturition. It is the most critical stage of the lactation cycle of high-producing dairy
cows. The period consists of a complex interplay of metabolic and hormonal adaptations,
inflammation, and immune activation. During the transition period, dairy cows
commonly face oxidative stress, an underlying factor for dysfunctional immune response
and enhanced inflammation, which can further increase the susceptibility of dairy cattle
to health disorders and decrease productivity. In the last few decades, there has been an
increased interest in studying alternative natural compounds with antioxidant and antiinflammatory properties as supplements for food-producing animals such as dairy cows.
The aim of this project was to evaluate the effects of carnosic acid, a phenolic diterpene
found in herbs from the Labiatae family, known for its antioxidant and antimicrobial
properties, on both in vivo and in vitro models. The first objective was to evaluate the
supplementation of carnosic acid on performance parameters and blood biomarkers of
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transition dairy cows. The findings of this study revealed that carnosic acid promoted
positive responses on inflammation and expression of oxidative stress biomarkers during
the period of infusions. In addition, carnosic acid tended to increase lactation
performance (e.g., milk yield and energy corrected milk), although the mechanisms
responsible for this response remain unclear. The second objective was to evaluate the
protective effects of carnosic acid on cultured mouse hepatocytes in response to oxidative
challenge. This in vitro study revealed that carnosic acid promoted increased viability and
antioxidant capacity through superoxide dismutase activity of mouse hepatocytes
subjected to hydrogen peroxide-induced oxidative cell damage. In summary, the
presented results reveal potential benefits of providing antioxidants such as carnosic acid
during periods of oxidative challenge, such as the peripartal period of dairy cows.

1

CHAPTER 1. LITERATURE REVIEW
Transition period
The transition period, also called the periparturient period, is commonly defined
as the last 3 wk before parturition to 3 wk after parturition (Grummer, 1995; Drackley,
1999) and is the most critical stage of the lactation cycle of high-producing dairy cows.
The period consists of a complex interplay of metabolic and hormonal adaptations,
inflammation, and immune activation (Pascottini et al., 2020).
Approximately 75% of the health disorders of lactating dairy cows (e. g., metritis,
ketosis, lipidosis) typically happen in the first month after calving (LeBlanc et al., 2006).
The high susceptibility to these diseases is mainly correlated with an impaired immune
response as a result of drastic metabolic and endocrine changes during the transition
period. Moreover, many of the metabolic disorders afflicting cows in the early postpartum period are interrelated and are associated with diet and management during the
prepartum period (Overton and Waldron, 2004).
Despite numerous studies on the nutrition and physiology of transition dairy
cows, this period remains a critical area for improvement on many dairy farms, with
health disorders continuing to occur and causing a negative economic impact on the dairy
industry. In fact, for decades, researchers, veterinarians, and nutritionists have tried to
find solutions to overcome the challenges of maintaining health and welfare during the
transition from late pregnancy to early lactation of high-producing dairy cows. Metabolic
conditions in early lactation are responsible for direct profit loss due to the costs
associated with disorders in clinical and subclinical forms and death of animals.
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Furthermore, for animals that recover from diseases in early lactation, their productive
potential over the entire lactation is likely compromised.
Physiology and metabolism
Negative energy balance
One of the main characteristics of the transition period is the drastic change in
nutrient demands, which requires metabolism coordination to meet the new requirements
for energy, glucose, amino acids, and calcium, to name a few (Overton and Waldron,
2004). The increase in nutrient requirements is mainly driven by fetal growth during the
prepartum period and by lactogenesis after calving. Interestingly, prepartum dairy cows
face a concomitant decrease in DMI prior to parturition, mainly related to physical,
behavioral, metabolic, and hormonal changes (Contreras and Sordillo, 2011). A dramatic
decline (around 20 to 40%) in DMI is commonly observed, particularly in the last week
of gestation, followed by a slow rate of increase in DMI after calving (Hayirli and
Grummer, 2004).
After parturition, however, the dietary intake is unable to meet the intense energy
requirements, especially of glucose associated with the onset of lactation (Esposito et al.,
2014; Lopreiato et al., 2020). The imbalance between the energy consumed and energy
needed is termed negative energy balance (NEB) (Sordillo and Raphael, 2013). In highproducing dairy cows, the NEB is further aggravated by nutrient prioritization towards
the mammary gland. In fact, after parturition, the energy demand for maintenance and
milk production in high-yielding dairy cows can reach three times the amount necessary
before parturition (Drackley et al., 2001; Weber et al., 2013). In this stage of reduced
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nutrient and energy availability, dairy cows adapt to the NEB by mobilizing body
reserves of different tissues, in particular fat tissue, and by turning skeletal muscle into a
site of use of fat-derived fuels, allowing glucose to be redirected to lactogenesis
(Contreras and Sordillo, 2011; Weber et al., 2013).
Lipid mobilization
In the adipose tissue, lipids are stored mainly as triacylglycerols (TAG), neutral
lipids containing 3 fatty acids esterified to the carbon backbone of a glycerol molecule
(Bolsoni-Lopes and Alonso-Vale, 2015). Lipid mobilization is a physiological adaptation
by mammals to times of reduced nutrient and energy availability, characterized by an
imbalance between lipogenesis (biosynthesis, incorporation, and storage of TAG in the
adipocytes) and lipolysis (sequential hydrolysis of TAG, fatty acids, and glycerol) in the
adipose tissue (Contreras and Sordillo, 2011).
In periods of high energy demands, as the onset of lactation, the adipocyte is
stimulated by hormones, mainly catecholamines, to increase lipolysis at the expense of
lipogenesis. The following is a series of intracellular reactions that culminate in the
activation of hormone-sensitive lipase (HSL) and adipose triglyceride lipase (ATGL),
enzymes responsible for about 95% of TAG hydrolysis (Bolsoni-Lopes and Alonso-Vale,
2015). From TAG hydrolysis, fatty acids are mainly released in the bloodstream bound to
albumins as non-esterified fatty acids (NEFA) and used as an energy source by different
tissues. At the same time, glycerol predominantly functions as a substrate for liver
gluconeogenesis (Nelson, 2005).
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During the transition period, lipidic mobilization is favored by a series of changes,
including reduced levels of plasma insulin and glucose, reduced insulin sensitivity in
adipose and other peripheral tissues, and increased levels of plasma catecholamines,
growth hormone (GH), and glucocorticoids (Contreras and Sordillo, 2011; Humer et al.,
2016). In the case of moderate lipid mobilization, plasma NEFA are used as an energy
source, which helps conserve glucose for milk synthesis and consequently increases
insulin concentrations, initiating a negative feedback to inhibit lipolysis.
However, when considering a high-yielding transition dairy cow, the intense lipid
mobilization and excessive plasma NEFA concentrations are thought to disrupt this
negative feedback mechanism. The high levels of plasma NEFA induce the expression of
tumor necrosis factor α (TNFα), a cytokine that interferes with insulin-dependent
reductions in lipase activity in the adipose tissue, further increasing the accumulation of
plasma NEFA (Sordillo and Raphael, 2013). In periparturient dairy cows, the excessive
post-partum body condition score reduction due to lipid mobilization and the consequent
increase in plasma NEFA have been associated with risk of metabolic diseases related to
intensive lipolysis (Contreras and Sordillo, 2011; McArt et al., 2013; Humer et al., 2016),
herd removal, reproductive difficulty, and reduced milk production (McArt et al., 2013).
Non-esterified fatty acids metabolism
Once released from the adipose tissue, NEFA circulate throughout the body in the
blood and be used as fuel by various tissues, such as muscle, mammary gland (for milk
fat synthesis), or taken up by the liver (McArt et al., 2013). The liver is capable of
removing around 15 to 20% of plasma NEFA, where they can be completely oxidized to
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generate energy for the liver, partially oxidized to produce ketone bodies, or re-esterified
into TAG, then either exported as very low-density lipoproteins (VLDL) or stored in the
liver as such (Ospina et al., 2010; McArt et al., 2013). The ketone bodies released by the
liver (acetone, acetoacetic acid, and mainly beta-hydroxybutyric acid [BHB]) can be used
as an additional energy source by tissues such as the brain and heart (McArt et al., 2013).
In the periparturient dairy cow, plasma NEFA starts to rise 2 to 3 wk before
calving, and peaks around calving or at the first week post-partum (Ingvartsen and
Andersen, 2000), and as the concentration of NEFA in the blood increases, so does their
uptake by hepatic tissue (Busato and Bionaz, 2020). The higher rates of NEFA entering
the liver during the transition period sometimes exceed the organ’s capacity to
completely oxidize TAG or secrete TAG as VLDL, resulting in an accumulation of TAG
in the liver and a greater production of ketone bodies by partial NEFA oxidation (Ospina
et al., 2010; Gross et al., 2013).
In early lactation, a moderate increase in the concentration of NEFA and BHB in
the blood is considered to be a normal adaptation to NEB. However, excessive
concentrations of these metabolites are an indication of a poor adaptive response to NEB
and intense lipid mobilization, and numerous studies have reported on the detrimental
effects of elevated NEFA and BHB on early lactation immune response, milk production,
and health events (McArt et al., 2013; McArt et al., 2015). During late lactation and most
of the dry period, dairy cows have a positive energy balance and plasma NEFA average
less than 0.2 mmol/L (Drackley, 2000; Contreras and Sordillo, 2011). The NEFA levels
start to increase 2 wk before parturition, and between calving and the first week of
lactation, NEFA can reach concentrations around 0.8 to 1.2 mmol/L, but should sharply
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decrease as lactation progresses (Drackley, 2000). Nevertheless, transition dairy cows on
a high lipid mobilization state are routinely exposed to circulation NEFA greater than 1.0
mmol/L, indicating a severe NEB (Drackley, 1999; Adewuyi et al., 2005; Busato and
Bionaz, 2020).
Metabolic disorders of transition dairy cows
Fatty liver syndrome
The severe lipid mobilization often observed in early lactation of transition dairy
cows is correlated with the development of fatty liver syndrome, also known as hepatic
lipidosis. Hepatic lipidosis develops when the lipid influx to the liver exceeds the organ’s
capacity for NEFA oxidation or VLDL synthesis (Gross et al., 2013). Fatty liver
primarily occurs in the first month after lactation, when up to 50% of cows would have
some degree of TAG accumulation in the liver (Jorritsma et al., 2000).
Although the NEFA concentration at which TAG starts to accumulate in the liver
is not well-established (Cooke et al., 2007), fatty liver syndrome is most likely to develop
during periods of elevated plasma NEFA concentrations because rates of TAG synthesis
are proportional to the NEFA supply to the hepatic tissue (Grummer, 1993). However,
the direct evaluation of fatty liver is assessed by chemical or histological analysis of TAG
within the liver tissue. Generally, fatty liver is categorized as normal, mild, moderate, or
severe when liver TAG as % of wet liver weight is <1%, 1-5%, 5-10%, and >10%,
respectively (Bobe et al., 2004). Depending on the level of histological and compositional
alterations of the hepatocytes, the incidence of this syndrome is associated with reduced
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metabolic function, health status, production, reproduction, and incidence of metabolic
disorders and infectious diseases (Bobe et al., 2004; Gross et al., 2013).
Nutritional risk factors for fatty liver development are related to increased
lipolysis or alterations in liver metabolism. The most common risk factors in the
prepartum period are obesity (BCS ≥ 4.0), feed restriction, excess energy diets, and long
calving intervals; while in the post-partum period, the occurrence of diseases and
infections, fasting, feed restrictions, and sudden feed changes are correlated with fatty
liver disease (Bobe et al., 2004; Kirovski and Sladojevic, 2017). In addition, Bobe et al.
(2004) indicate that environmental stressors such as heat stress, overcrowding, and
excessive pen movements, contribute to fatty liver development, mainly through
decreasing dry matter intake.
Regarding the nutritional and management approaches for prevention of fatty
liver, along with adequate control of the cited risk factors, Grummer (2008) stated that
strategies could be subdivided as: (1) reducing lipolysis in adipose tissue; (2) increasing
complete NEFA oxidation; and (3) increasing VLDL export from the liver. In this
context, nutritional practices have been applied to prevent or treat fatty liver, especially
by increasing VLDL secretion, since this mechanism is very limited in ruminants
compared with other species (Kirovski and Sladojevic, 2017). Supplementation of
substrates for the synthesis of VLDL such as choline increased VLDL secretion and
alleviated TAG accumulation in the liver of dairy cows (Cooke et al., 2007; Coleman et
al., 2019).
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Ketosis
Ketosis is a metabolic disorder of common occurrence during early lactation,
developed as a consequence of poor adaptive response to NEB and lipid mobilization
(McArt et al., 2012). In the hepatic tissue, NEFA are broken down via -oxidation into
acetyl coenzyme A (acetyl-CoA). Acetyl-CoA then undergoes complete oxidation
through the citric acid cycle to generate energy as ATP. However, during intense lipidic
mobilization, increased levels of acetyl-CoA lead to an overload of the citric acid cycle,
with depletion of its intermediates, resulting in increased ketogenesis, with the production
of acetoacetic acid, acetone, and BHB. The synthesis of ketone bodies beyond the
capacity of extrahepatic tissues to oxidize them leads to an increased concentration in
body fluids, especially blood, where ketone bodies can lower pH and cause metabolic
acidosis (Nelson, 2005).
Hyperketonemia has been defined as blood BHB concentrations above 1.4
µmol/L by some authors (e.g., Oetzel, 2004) and as concentrations above 1.2 µmol/L by
others (e.g., McArt et al., 2012). Hyperketonemia can be manifested clinically as a drastic
decrease in feed intake, body weight, and milk production (clinical ketosis, CK), but most
likely as subclinical ketosis (SCK), with elevated blood ketone bodies without clinical
signs (Oetzel, 2004; McArt et al., 2012). In addition to the direct profit loss associated
with impaired milk production and treatment costs, elevated blood concentrations of
ketone bodies have also been correlated with decreased reproduction performance and
increased probability of other health disorders such as displaced abomasum and mastitis
(Steeneveld et al., 2020).

9

Ketosis is mainly associated with early lactation of high-yield cows, with peak
prevalence around the first week of lactation (McArt et al., 2012) and with more than
90% of SCK occurring in the first and second months post-partum (Rutherford et al.,
2016). Although its incidence is widely variable among literature, depending on the
diagnostic method and frequency of screening, consensus is that SCK has a higher
incidence than CK. Overall, the incidence of CK in the first month of lactation is
expected to be around 2 to 15%, whereas for SCK, the incidence can reach values greater
than 40% during the same period (McArt et al., 2012; Gordon et al., 2013; Rutherford et
al., 2016).
Immune system
The immune system can be defined as an interactive system of cells, tissues, and
their soluble products that recognize, attack, and destroy pathogens that could endanger
the homeostatic status of an organism (Mak et al., 2014a). The mammalian immune
system can be divided into innate and acquired (also called adaptive) immune systems.
These two immune systems are interconnected (Parkin and Cohen, 2001). While the
innate immune system has a broad scope with the capacity to respond to tissue injury or
neutralize a variety of potential pathogens, the adaptive immune system is a more specific
response to infectious pathogens and can be augmented by repeated exposure to the same
pathogen (Sordillo, 2016).
Innate immune system
Innate immune defenses in mammals are present in virtually all tissues. The
innate immune response is typically rapid, and in contrast with the adaptive immune
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system, traditionally described as lacking memory (Gasteiger et al., 2017). The main
components of the innate immune system are physical barriers, pattern recognition
receptors, complement, cytokines, and cellular components, which include endothelial,
neutrophils, macrophages, monocytes, dendritic, and natural killer cells (Sordillo, 2016).
The very first line of defense against the entry of microorganisms and toxic
molecules into the body are the physical barriers (mechanical, chemical, and biological).
The mechanical barriers include the epidermis and keratinocytes of the skin and the GI
and respiratory tract epithelium. The chemical barriers constitute pH secretions, and
microbicidal molecules secreted from different tissues (e.g., skin, respiratory and
gastrointestinal tract). In addition, commensal microbes in the skin and GI tract exist in
symbiosis with the body and inhibit pathogens’ growth (Doan, 2013).
When invading pathogens successfully break the mechanical barriers defenses,
pattern recognition receptors (PRR) play a critical role in sensing their presence (Sordillo,
2016). The PRR are protein germline-encoded receptors capable of recognizing
molecules frequently found in pathogens [called Pathogen-Associated Molecular Patterns
(PAMPs)], or molecules released by damaged cells [called Damage-Associated
Molecular Patterns (DAMPs)] (Gasteiger et al., 2017; Amarante-Mendes et al., 2018).
Some examples of PAMP that can be recognized by PRRs include lipopeptides of grampositive bacteria and LPS of gram-negative bacteria (Sordillo, 2016). Upon PAMP and
DAMP sensing, PRR signal to the host the presence of infection and trigger
proinflammatory and antimicrobial responses by activation of gene expression and
synthesis of a series of molecules, including cytokines, cell adhesion molecules, and
immunoreceptors (Mogensen, 2009; Kumar et al., 2011).
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Cytokines are chemicals mainly secreted by immune cells and are one of the most
important soluble defense mechanisms of the innate immune system. Cytokines act in a
non-specific manner and are involved in a great variety of biological functions. For
example, interleukin-1 (IL-1) is a cytokine that acts in the vascular endothelium,
increasing its permeability to immune cells. Interleukin-8 (IL-8) also acts on the vascular
endothelium, and its function is related to vascular endothelium activation and neutrophil
attraction and activation (Doan, 2013).
In addition to the physical barriers and soluble components, the innate immune
system includes cellular defenses, essential for an effective response against pathogens.
Cellular defenses include neutrophils, a type of polymorphonuclear leukocytes (PMNL)
(Doan, 2013; Sordillo, 2016). In response to local chemokine gradients, neutrophils are
the first cells recruited to the site of inflammation. Once there, neutrophils are activated
by binding their PRR to DAMPs or PAMPs. Neutrophils try to contain the foreign
entities by phagocytosis, or when containment is not possible, they attempt to destroy
pathogens by releasing destructive contents of their granules extracellularly, in a process
called degranulation. Other cellular components include dendritic cells, monocytes, and
macrophages, which are also phagocytic immune cells. Those cells also have the capacity
to produce cytokines, which regulate or promote inflammation (Mak et al., 2014b).
Acute phase proteins
The acute phase proteins (APP) are blood proteins synthesized mainly by the liver
and peripheral tissues (Ceciliani et al., 2012; Schneider, 2015). By definition, these
proteins change their concentration by >25% in response to proinflammatory cytokines
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stimulated during the onset of a disease (Eckersall and Bell, 2010). Acute phase proteins
are believed to play major roles in the systemic reaction to inflammation, including
opsonization, scavenging of toxic substances, and regulation of different stages of the
inflammatory process (Ceciliani et al., 2012). Moreover, they are highly sensitive
indicators of inflammation and can be used in disease diagnosis, prognosis, monitoring
response to treatment, and general health screening (Eckersall and Bell, 2010).
Normal parturition in dairy cows is characterized by inflammatory-like
conditions, during which proinflammatory cytokines, such as TNFα, IL-1, and IL-6, are
produced in large amounts by immune cells. These cytokines can stimulate the liver to
synthesize positive APP, such as haptoglobin or ceruloplasmin. In contrast, cytokines can
impair the synthesis of negative APP (e.g., albumin and cholesterol), some of them
important for normal liver metabolism (Bionaz et al., 2007). In cattle, haptoglobin and
serum amyloid A (SAA) are considered major APP, meaning their concentration can
increase up to and over 100-fold following inflammation (Thomas et al., 2015), whereas
ceruloplasmin is classified as moderate or minor APP (Ceciliani et al., 2012).
Haptoglobin is considered a scavenger protein through its binding capacity.
Haptoglobin eliminates metabolites such as free hemoglobin released from cellular
degradation, helping to prevent oxidative tissue damage (Ceciliani et al., 2012; Moisa et
al., 2019). Following parturition, high haptoglobin concentrations have been associated
with leukocyte responses in dairy cows, including increased neutrophil surface
expression of L-selectin and oxidative burst (Moisa et al., 2019). In contrast,
ceruloplasmin is a copper carrier protein that oxidizes ferrous ions and has antioxidant
and anti-inflammatory activity (Murata et al., 2004).

13

Periparturient immune dysfunction
The transition period is characterized by drastic physiological changes. Those
changes include alterations in the immune system of the periparturient cow that
ultimately lead to a reduction in immune competence and a concomitant systemic
inflammatory response (Aleri et al., 2016; Trevisi and Minuti, 2018). It is clear that cows
show an inflammatory condition from calving until around three weeks after parturition
(Bertoni and Trevisi, 2013; Ingvartsen and Moyes, 2015; Trevisi and Minuti, 2018);
changes in the immune system often proceed parturition (Kehrli et al., 1989a; b; Mezzetti
et al., 2019). The prepartal immune alterations are correlated with a combination of
endocrine and metabolic changes. However, it remains to be elucidated if the reduced
immune competence is a physiological condition of transition dairy cows or an early
signal of disease (Trevisi and Minuti, 2018).
Interestingly, the inflammatory state and positive acute phase mediators are
present on the days following calving even in the absence of signs of microbial infections
or other pathologies (Bionaz et al., 2007; Sordillo and Aitken, 2009; Bertoni and Trevisi,
2013). To some extent, the tissue damage associated with parturition and subsequent
uterine involution and social stress of parturition contribute to the systemic inflammation
of the transition cow (Bradford et al., 2015). Moreover, changes in the hormonal
environment, especially the increase in glucocorticoids, have been associated with
immunosuppression. However, these hormones are elevated for only 24 hours around
parturition. Therefore, they could not alone explain the immune changes of the postpartum dairy cow, which remain for weeks following calving (Overton and Waldron,
2004; Ingvartsen and Moyes, 2015).
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In addition to endocrine factors, several studies have correlated peripartal
alterations in energy metabolism and nutrient supply with immunosuppression and
immune dysfunction of dairy cows. Immune cells are affected by blood glucose levels,
which is their preferred metabolic fuel rather than fatty acids, amino acids, or ketone
bodies (Calder et al., 2007; Ingvartsen and Moyes, 2015). Additionally, glucose
stimulates leukocyte immune response, including increased proliferation, differentiation,
survival, chemotaxis, and phagocytosis (Ingvartsen and Moyes, 2013; Ingvartsen and
Moyes, 2015). During early lactation, due to increased nutrient demands by the
mammary gland, serum concentrations of glucose reach its nadir, and low glucose
availability may limit immune function and increase risk of infection (Ingvartsen and
Moyes, 2013). Furthermore, the lower blood calcium around parturition negatively
impacts neutrophil activity. Intracellular calcium signaling is key in neutrophil activation
and function (i.e., phagocytosis). Therefore, hypocalcemia around calving may also
contribute to impaired immune response and greater susceptibility to diseases around
calving (Ducusin et al., 2003; LeBlanc, 2020).
The low concentrations of glucose and calcium following parturition are often
accompanied by increased levels of blood BHB and NEFA. In contrast with glucose, both
BHB and NEFA have immunosuppressive effects and increase inflammation around
parturition. Elevated levels of NEFA have been associated with impaired lymphocyte
function (Lacetera et al., 2005; Ster et al., 2012), reduction in PMNL viability and killing
ability, and increased neutrophils ROS production (Hammon et al., 2006; Scalia et al.,
2006). In addition, NEFA has been demonstrated to enhance the proinflammatory
phenotype of endothelial cells and to activate NF-кB signaling pathways, which can
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induce the expression of several adhesion molecules, proinflammatory cytokines, and
chemokines (Contreras and Sordillo, 2011; Contreras et al., 2012). Elevated
concentrations of BHB decrease neutrophil phagocytosis, extracellular trap formation
(Grinberg et al., 2008), and chemotaxis (Suriyasathaporn et al., 1999).
Oxidative stress
Oxidative stress can be defined as the damage occurring to cellular
macromolecules as a consequence of a serious imbalance between oxidants and
antioxidants (Halliwell, 2007; Mavangira and Sordillo, 2018). Oxidative damage has
negative effects, especially on lipids, proteins, and DNA, and has been associated with
the development of several pathologies. Reactive oxygen species (ROS) are the most
abundant oxidants. However, reactive nitrogen species (RNS) also contribute to the
overall oxidant pool (Mavangira and Sordillo, 2018). Commonly, RNS (e.g., nitroxide,
peroxy-nitrite, and nitrogen dioxide) have been ascribed to ROS (Abuelo et al., 2015).
Reactive oxygen species
Reactive oxygen species are used in literature as a general term to describe
different chemically reactive oxygen radicals as well as non-radical derivatives of oxygen
(Patel et al., 2018). They are a consequence of the requirement of molecular oxygen as an
electron donor for efficient energy production in aerobic organisms. Reactive oxygen
species are mostly formed as normal end products of cellular metabolism of the
mitochondrial electron transport chain (Sordillo and Aitken, 2009). In fact, in actively
respiring mitochondria, 0.1% to 4% of O2 used in respiration forms ROS (Nelson, 2005).
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Other than mitochondrial respiration, sources of ROS production include the
processes of the enzymes nicotinamide adenine dinucleotide phosphate oxidase (NADPH
oxidase), xanthine oxidoreductase, and myeloperoxidase (Patel et al., 2018). In
mammalian cells, the biological sources of ROS also include endoplasmic reticulum,
peroxisomes, cytosol, plasma membrane, and extracellular space (Ozcan and Ogun,
2015).
Reactive oxygen species include the free radicals superoxide anion (O2-•),
hydroxyl radical (OH•), and hydroperoxyl (HO2•), and the non-radicals hydrogen
peroxide (H2O2), hypochlorous acid (HOCl-), and single oxygen (1O2) (Sordillo and
Raphael, 2013). There are many enzymatic pathways in which ROS are produced in the
cell, and most pathways are initiated by the production of superoxide (Patel et al., 2018).
The superoxide anion is a highly reactive free radical produced mainly in the
mitochondria, and its formation also leads to the production of a variety of other ROS,
including hydroxyl free radical, which is even more reactive (Nelson, 2005; Sordillo and
Aitken, 2009).
Reactive oxygen species physiological and pathological effects
Low to moderate concentrations of ROS are necessary for the regulation of
physiological processes and redox homeostasis, such as cell differentiation and
proliferation (Sordillo and Raphael, 2013; Abuelo et al., 2015). In the host immune
response, ROS play an important role in the destruction of pathogens and the expression
of immunoregulatory substances (Abuelo et al., 2015). In addition, according to Nelson
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(2005), low levels of ROS may be used as an indicator of insufficient oxygen supply,
triggering metabolic changes.
Immune phagocytes, such as macrophages, neutrophils, and dendritic cells, can
produce ROS in their endosomes through NADPH oxidase activity. Following the
engulfing of pathogens by phagocytosis, these immune cells degrade the invasive
organism by releasing ROS from their cytoplasmic granules (Sordillo and Raphael, 2013;
Patel et al., 2018). This mechanism is named oxidative burst and is one of the
components of an effective first line of defense of the innate immune system (Pascottini
et al., 2019).
Although ROS are essential physiological functions, their concentrations are
finely regulated by several endogenous antioxidant defense mechanisms. In cases of
redox imbalance, either by increased production of ROS or failure of the defense
mechanisms, the consequent oxidative stress results in the occurrence of various
deleterious processes that could ultimately lead to cell death. Among the most susceptible
molecules to ROS damage is DNA. This damage has detrimental effects, including
carcinogenesis, mutations, genome instability, and cell signaling alterations (Sordillo and
Raphael, 2013; Surai et al., 2019).
The complex structure of proteins, aligned to the presence of oxidizable
functional groups (e.g., thiol (─SH) found on cysteine residues), results in susceptibility
to oxidative damage (Patel et al., 2018; Surai et al., 2019). Overall, protein oxidation can
alter their functional structure and consequently compromising their biological activity.
Moreover, lipids, especially the phospholipids present in the cell membrane, are
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susceptible to peroxidation and the subsequent formation of lipid radicals (Sordillo and
Raphael, 2013). These lipid radicals can stimulate the oxidation of adjacent fatty acids,
entering a vicious cycle that can lead to membrane function loss and cell death (Abuelo et
al., 2015).
Antioxidant mechanisms
Antioxidant defense systems are believed to have evolved as a means of surviving
in an oxygenated atmosphere (Surai et al., 2019). Animal antioxidant mechanisms are
based mainly on the presence of biological compounds named antioxidants, either
biologically synthesized or provided in the diet (Surai et al., 2019). In general terms,
antioxidants can be defined as any substance that delays, prevents, or removes oxidative
damage to a target molecule (Halliwell, 2007).
The antioxidant network operates at both cellular and subcellular levels and is
based on several lines of defense. These antioxidant strategies include direct scavenger of
ROS, antioxidant recycling, metal binding and chelating, removal of damaged molecules,
and decreased activity of pro-oxidant enzymes, among others (Surai et al., 2017; Surai et
al., 2019). Antioxidant compounds can be further classified based on several methods,
such as solubility in lipids or water. Most commonly, antioxidants are divided based on
their chemical and physical characteristics as enzymatic or nonenzymatic (Sordillo and
Aitken, 2009; Morillas-Ruiz and Hernández-Sánchez, 2015).
The main antioxidant enzymes are superoxide dismutase (SOD, which reduces
superoxide anion), catalase (CAT, catalyzes the reduction of hydrogen peroxide), and
glutathione peroxidase (GPx, catalyzes the degradation of hydrogen peroxide and organic

19

peroxides). Nonenzymatic antioxidants include glutathione, ascorbic acid (vitamin C), αtocopherol (vitamin E), β-carotene (vitamin A), uric acid, polyphenols, and others
(Sordillo and Raphael, 2013; Morillas-Ruiz and Hernández-Sánchez, 2015). Vitamin C is
known as a radical scavenger, while vitamins E and A have a vital function in preventing
and disrupting fatty acid peroxidation chain reaction, respectively (Sordillo, 2016).
Oxidative stress of transition dairy cows
During the transition period, dairy cows undergo a shift from a gestational
nonlactating state to a state of copious milk synthesis and secretion, demanding metabolic
adjustments to the dramatic increase in energy requirements (Sordillo and Raphael,
2013). This period of enhanced metabolism leads to a considerable increase in oxygen
requirements and the consequent production of oxidants (Sordillo and Aitken, 2009;
Abuelo et al., 2015; Abuelo et al., 2016a). In particular, the intensified processes of
NEFA β-oxidation in the liver, characteristic of the negative energy balance during the
transition period, results in the increased production of ROS (Turk et al., 2013). In
addition to the increased ROS production in the liver, the proinflammatory state of the
transition dairy cow also contributes to alterations in redox balance. This mechanism
occurs through the release of cytokines, which can induce ROS production by both
phagocytic and non-phagocytic cells (Thannickal and Fanburg, 2000; Valko et al., 2007).
Following parturition, ROS production often exceeds the antioxidant capacity of
the tissues, leading to a progressive development of oxidative stress (Abuelo et al., 2015;
Abuelo et al., 2016a). Oxidative stress can further increase dysfunctional inflammation
and metabolic stress (Figure 1.1), creating a vicious cycle that ultimately leads to tissue
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damage, increased risk of health disorders, and decreased milk production and
reproduction of the transition dairy cow. In immune cells, alterations in redox balance
can result in diminished functional activities, such as reduction in neutrophil
phagocytosis and killing capacity (Sordillo and Aitken, 2009). In addition, oxidative
stress has been correlated with increased inflammation by activating proinflammatory
signaling pathways (Sordillo and Raphael, 2013) such as NF-кB, and increased
expression of proinflammatory mediators (i.e., TNFα and IL-6). Furthermore, oxidative
status has been associated with insulin resistance in periparturient dairy cattle, which, in
turn, can further enhance the lipolytic state during the transition period (Abuelo et al.,
2016b).
Overall, oxidative stress is an underlying factor for dysfunctional immune
response and inflammation, which underscores the importance of this condition in
increasing the susceptibility of dairy cattle to health disorders, particularly during the
transition period (Bernabucci et al., 2005; Sordillo and Aitken, 2009; Abuelo et al.,
2015). Therefore, during this period of high antioxidant demands, dietary
supplementation with antioxidants is recommended to meet the increased requirements
(NRC, 2001; Spears and Weiss, 2008; Abuelo et al., 2019).
In dairy cattle, vitamin E and selenium are the most widely used antioxidants
included in diets, especially in the form of premixes added to the total mixed ration
(Abuelo et al., 2015). Although the NRC (2001) acknowledged that additional vitamin E
might be useful during periods of immunosuppression such as the peripartal period,
several factors seem to influence the recommended values for antioxidants requirement.
The supplementation of antioxidants has been mostly beneficial for animal health status
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(Politis et al., 1995; Politis et al., 1996). However, recent studies have reported
deleterious effects of excessive supplementation of antioxidants. For example, provisions
of 3,000 IU of vitamin E, which exceeds NRC standards, increased the risk of mastitis
and oxidative stress in the postpartum period of transition dairy cows (Bouwstra et al.,
2010a; Bouwstra et al., 2010b).
Use of nutraceuticals during the transition period of dairy cows
For decades, researchers, veterinarians, and nutritionists in the dairy industry have
been trying to overcome the challenges of maintaining health and welfare during the
transition period of high-producing dairy cows. The complexity of the physiological
changes around parturition, aligned with the direct effects of energy and nutrient status on
immune function, makes this period particularly challenging, requiring the application of
multiples strategies to allow a better transition into lactation. In general, the nutritional
management strategies of transition dairy cows aim to meet glucose demands, decrease
excessive lipid mobilization, reduce TAG accumulation in the liver, prevent
hypocalcemia, and ultimately, reduce immune dysfunction and the incidence of health
disorders (Overton and Waldron, 2004; Sordillo, 2016).
The dairy industry has recently faced an increased consumer preference for
healthier and natural food sources, including concern for animal welfare and decreased
use of antibiotics. In contrast to antimicrobial drugs used to treat diseases, strategies that
target host responses through nutrition can minimize drug residues and the possibility of
developing drug-resistant pathogens (Sordillo, 2016). There has been an increased
interest in supplementing feed with alternative natural compounds with antimicrobial,
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antiparasitic, and immunomodulation properties for food-producing animals (Yang et al.,
2015; Ciampi et al., 2020; Lopreiato et al., 2020). These alternative compounds have
become a focus for researchers and producers because their beneficial effects may be
transferred to the final products for the human diet, which are positively perceived by
consumers while maintaining a profitable margin for dairy farm operations (Abuelo et al.,
2019; Bhagat et al., 2019).
These alternative natural compounds are often referred to as “nutraceuticals” as
their health benefits reach beyond nutritional value. Nutraceuticals interact at different
levels of the animal’s physiology and are considered between the lines of feed and a drug
(Yurdakok-Dikmen and Filazi, 2019; Lopreiato et al., 2020). Nutraceuticals are mostly
multi-target polypharmacological agents, presenting antioxidants and anti-inflammatory
properties, along with benefits in terms of cell survival, differentiation, and proliferation
(Dormán et al., 2016; Lopreiato et al., 2020), making their supplementation particularly
beneficial during the transition period of high-producing dairy cows. However, regardless
of potential applications, due to their classification as “dietary supplements”, these
natural compounds lack governmental regulations and information regarding
composition, dosages, effectiveness, and quality, which are not necessarily validated
(Ballou et al., 2019).
Nutraceuticals can be classified in many ways based on their mechanism of
action, chemical structure, and source, among others. In a recent review, Ballou et al.
(2019) classified the nutraceuticals currently available for ruminants into: 1) probiotics,
2) prebiotics, 3) phytonutrients, or 4) polyunsaturated fatty acids. Probiotics confer
beneficial health effects on the host mainly by improving the balance of the healthy
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microflora (beneficial bacteria), enhancing mucosal immunity, increasing digestive
capacity, and preventing colonization of harmful bacteria (Yurdakok-Dikmen and Filazi,
2019). A multi-strain probiotic supplement containing Saccharomyces cerevisiae and
Lactobacillus sporogenes improved milk yield, fat corrected milk (FCM), and milk solids
in early to mid-lactating dairy cows (Shreedhar et al., 2016). In addition, dairy cows
supplemented with Lactobacillus casei and Lactobacillus plantarum from 60 to 90 DIM
had increased milk production and lower SCC than control cows (Xu et al., 2017).
Prebiotics are defined as indigestible carbohydrates, such as oligosaccharides and
fructans, that serve as an energy source for commensal or probiotic bacteria in the rumen
and lower GIT (Ballou et al., 2019). Yeast culture products from Saccharomyces
cerevisiae have improved energy corrected milk (ECM), decreased SCC, and increased
abundance of cellulolytic and lactate-utilizing bacteria in transition dairy cows (Carpinelli
et al., 2021) while promoting more neutral rumen pH and greater total VFA in lactating
dairy cows (Halfen et al., 2021).
Another classification of nutraceuticals is phytonutrients, also known as
phytochemicals, plant-derived bioactive compounds with various chemical structures and
biological activities (Oh et al., 2017; Yurdakok-Dikmen and Filazi, 2019). Major
phytonutrients used in farming systems include phenolic compounds, saponins, and
essential oils (Vasta and Luciano, 2011; Yurdakok-Dikmen and Filazi, 2019).
Phytonutrients have been investigated as feed additivities for their potential use as
antioxidants, antimicrobials (Hammer et al., 1999), immune stimulators, and modulators
of rumen fermentation (Wallace, 2004).
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Polyphenol compounds represent a family of phytochemicals of about 500
different molecules with potential therapeutic applications due to their intrinsic
antioxidative and anti-inflammatory properties (Ballou et al., 2019; Lopreiato et al.,
2020). Some of the more common plants containing polyphenols include thyme and
oregano, clove, juniper, cinnamon, hot peppers, garlic, aloe, yerba mate, pomegranate,
silymarin, and green tea (Lopreiato et al., 2020). Mezzetti et al. (2020) reported positive
effects on liver function and redox balance when transition dairy cows were
supplemented with Aloe arborescens, while Ciampi et al. (2020) observed that
pomegranate extract had the potential to mitigate oxidative stress without detrimental
effects on bovine endothelial cell viability in vitro.
Carnosic acid
Herbs from the Labiatae family, especially common salvia (Salvia officinalis) and
rosemary (Salvia rosmarinus), are known to have a particularly high concentration of
phenolic diterpenes with antioxidant and antimicrobial properties, such as carnosic acid,
carnosol, and rosmarinic acid (Birtic et al., 2015; Loussouarn et al., 2017). Among these
phenolic diterpenes, carnosic acid is the most abundant in rosemary leaves, where they
can reach values greater than 10 mg/g of fresh weight (Luis and Johnson, 2005), and it
has one of the highest antioxidant activities (Cuvelier et al., 1994; Okamura et al., 1994).
Carnosic acid has a high reactivity toward ROS and acts as a scavenger that can
eliminate ROS (Birtic et al., 2015). Moreover, carnosic acid plays a role in the activation
of the PI3K/Akt/NRF2 signaling pathway in human cells (de Oliveira et al., 2015; de
Oliveira et al., 2016). Nuclear factor erythroid-2 related factor 2 (NRF2) is a transcription
factor involved in the cellular response to oxidative stress, inducing the expression of
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several protective enzymes, such as glutathione peroxidase and superoxide dismutase (de
Oliveira et al., 2016). Carnosic acid has also been correlated with reduced expression
levels of proinflammatory cytokines, e.g., IL-1, IL-6, and TNFα in human and mice cells
through the NF-κB signaling pathway (Liu et al., 2019; Hosokawa et al., 2020).
Moreover, carnosic acid suppresses hepatic steatosis in high-fat diet-fed mice through the
downregulation of hepatic genes related to fatty acid synthesis (e.g., fatty acid synthase)
and upregulation of hepatic genes related to β-oxidation (e.g., PPARα, peroxisome
proliferator-activated receptor-α) (Park and Mun, 2013).
A summary of recent studies supplementing rosemary extracts and leaves in
ruminant species and their main findings can be found in Table 1. In ruminant species,
studies evaluating carnosic acid and rosemary supplementation have been associated with
an increase in meat quality and milk production of goats and sheep. Surprisingly, the
strategy used by carnosic acid to reduce the oxidative and metabolic stress of transition
dairy cows has not been explored until the present moment.
RATIONALE AND OBJECTIVES
The overall goal of this project was to explore the effects of carnosic acid on
biological models of oxidative stress. Therefore, the objectives of this study were to
evaluate the supplementation of carnosic acid on: a) performance parameters and blood
biomarkers of transition dairy cows infused with carnosic acid; and b) protective effects
of carnosic acid on cultured mouse hepatocytes in response to oxidative challenge. To the
best of our knowledge, carnosic acid has never been studied as a nutraceutical in dairy or
beef cattle, and it could represent a breakthrough in oxidative stress protection in
transition dairy cows. Based on the anti-inflammatory and antioxidant properties of

26

carnosic acid, we hypothesized that carnosic acid would have cytoprotective effects in
cultured mouse hepatocytes subjected to hydrogen peroxide-induced oxidative cell
damage. Moreover, considering its chemical properties and previous studies using
different animal models, we hypothesized that providing carnosic acid during early
lactation might minimize the typical exposure to oxidative stress and attenuate the typical
inflammatory response during the peripartum period while allowing cows to reach peak
performance.
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Figure 1.1. Schematic illustration of the interplay between antioxidant supplementation,
metabolic stress, dysfunctional inflammation and presented health disorders.
Source: Abuelo et al. (2015).
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Table 1.1. Studies with carnosic acid and rosemary supplementation in different ruminant species.
Subject

Supplement

22 lambs

Carnosic acid

Dose

Period of
supplementation

Effect

Reference

5 wks

Delayed lipid peroxidation in the
meat.

Moran et al.
(2012)

56 d

Transfer of CA to meat; increased
antioxidant status of meat.

Jordan et al.
(2014)

240 d

Lower lipid oxidation, higher colour
stability

Nieto et al.
(2010)

0 to 154 DIM

Higher doses of rosemary extract
increased milk yield, protein (%),
casein (g), and lactose (% and g).

Chiofalo et al.
(2010)

80 d

Greater milk, milk fat and milk
protein production.

Smeti et al.
(2015)

Greater nutrient digestibility, and
ruminal fermentation. Increased milk
yield and positive effects on milk
fatty acid profile.

Kholif et al.
(2017)

0.6 g/kg of DM;
1.2 g/kg of DM
640 ppm of 1:1 CA: carnosol;
30 lambs

Rosemary extract
685 ppm of 2:1 CA: carnosol
10% or 20% of basal diet

36 sheep
and 27
lambs

Rosemary leaves

36 sheep

Rosemary extract

(pellet of 50% barley and 50%
distilled rosemary leaves)
600 mg/head/d
1200 mg/head/d
Rosemary leaves: 60 g/kg of DM

30 dairy
goats

15 dairy
goats

Rosemary leaves or
extract

Rosemary leaves

Rosemary extract: 0.6 g/kg of
DM

10 g/head/d

12 wks

10% or 20% of basal diet
36 dairy
goats

Rosemary leaves

(pellet of 50% barley and 50%
distilled rosemary leaves)

224 d

Alter neither yield nor milk quality.
Increased concentration of
polyphenols components in the milk
and in the plasma of the suckling
goat kid.

Jordan et al.
(2010)
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CHAPTER 2. AN EXPLORATION OF THE EFFECTS OF AN EARLY
POSTPARTUM INTRAVENOUS INFUSION WITH CARNOSIC ACID ON
PHYSIOLOGICAL RESPONSES OF TRANSITION DAIRY COWS
Abstract
The objective of the present study was to evaluate the effects of an antioxidant and antiinflammatory compound found in rosemary plants (Salvia rosmarinus) named carnosic
acid during the transition period of dairy cows. From day 1 to 3 after calving, 16
multiparous Holstein cows received a daily intravenous infusion of either 500 mL of
saline (NaCl 0.9%; Saline; n = 8) or carnosic acid at a rate of 0.3 mg/kg of BW supplied
in 500 mL of saline (CA; n = 8). Blood samples were taken at –7, 2, 5, 7, 14, and 21 d
relative to parturition, then analyzed for metabolites related to energy metabolism,
muscle mass catabolism, liver function, inflammation, and oxidative stress. Infusion of
CA tended to improve milk performance; however, DMI was unaffected by treatment. At
2 d relative to parturition, CA cows had lower blood concentrations of haptoglobin,
paraoxonase, FRAP, and NO2– than saline cows. After treatment infusions, haptoglobin
remained lower in CA cows than saline at 5 d relative to parturition. Our results
demonstrate that carnosic acid promoted positive responses on inflammation and
oxidative stress biomarkers and may promote beneficial effects on lactation performance
in peripartal dairy cows.
Keywords: peripartum; oxidative stress; carnosic acid
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Introduction
The transition from pregnancy to lactation is one of the more stressful periods of a
dairy cow’s life. Approximately 75% of health disorders in adult cows, such as retained
placenta, mastitis, and metritis, typically occur within the first month after calving
(LeBlanc et al., 2006). The high susceptibility to these diseases is mainly correlated with
an impaired immune response, a result of drastic metabolic and endocrine changes during
the transition period.
From a metabolic standpoint, dairy cows commonly experience increased energy
requirements during the transition period, primarily for fetal growth prepartum, followed
by milk synthesis postpartum (Drackley, 1999; Sordillo and Aitken, 2009). Cows showed
a clear inflammatory response (Bertoni and Trevisi, 2013; Trevisi and Minuti, 2018) after
calving, although changes in immune response often proceeded parturition (Kehrli et al.,
1989a; b; Mezzetti et al., 2019a). Additionally, during the prepartum period, cows
commonly experienced a decrease in dry matter intake (DMI) (Hayirli and Grummer,
2004). Although immediately after parturition, there is a progressive increase in feed
intake, which generally cannot meet nutrient requirements in early lactation. Therefore, a
negative energy balance (NEB) condition is reached, and consequently, non-esterified
fatty acids (NEFA) are mobilized from the adipose tissue to meet nutrient requirements
(Contreras and Sordillo, 2011; Abuelo et al., 2015).
During NEB, triacylglycerides (TAG) are hydrolyzed into glycerol and NEFA
and released into the bloodstream (Nelson, 2005). The NEFA can be used as an energy
source by different tissues, such as the mammary gland for milk fat synthesis, or taken up
by the liver (McArt et al., 2013). In the liver, NEFA are either completely oxidized to
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generate energy, partially oxidized to produce ketone bodies, or re-esterified into TAG.
Then, TAG are either exported as very low-density lipoproteins (VLDL) or stored in the
hepatocytes (Ospina et al., 2010; McArt et al., 2013). At periods of intense lipid
mobilization, like the transition period, NEFA entering the liver exceeds its capacity for
β-oxidation and VLDL secretion, which leads to a greater production of ketone bodies,
such as β-hydroxybutyrate (BHB), and the accumulation of TAG in the liver (Ospina et
al., 2010; Gross et al., 2013).
The increased plasma NEFA and BHB, aligned with augmented metabolic
demand characteristic of the transition period, is commonly accompanied by a surge in
reactive oxygen species (ROS) leading to oxidative stress (Sordillo and Raphael, 2013;
Abuelo et al., 2015). In parallel, the proinflammatory cytokines released by the immune
system induce ROS production by both phagocytic and non-phagocytic cells (Abuelo et
al., 2015), which can further alter redox balance and lead to an oxidative stress condition
during early postpartum period. Oxidative stress is defined as the damage occurring to
cellular macromolecules as a consequence of serious and prolonged imbalance between
oxidants and antioxidants (Halliwell, 2007b; Mavangira and Sordillo, 2018).
The ROS are particularly reactive towards DNA, proteins, and lipids, resulting in
cellular alterations, including lipid peroxidation, cell membrane damage, DNA mutation,
impaired protein activity, and cell death (Sordillo and Raphael, 2013; Abuelo et al.,
2016b; Mavangira and Sordillo, 2018). In immune cells, those alterations can result in
diminished functional activities, such as reduction in neutrophil phagocytosis and killing
capacity (Sordillo and Aitken, 2009). In addition, oxidative stress has been correlated
with increased inflammation through the activation of proinflammatory signaling
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pathways (Sordillo and Raphael, 2013) and with insulin resistance, which can further
enhance the lipolytic state of transition dairy cows (Abuelo et al., 2016b). Taken together,
increased oxidative stress is associated with a dysfunctional immune response and
enhanced inflammation, resulting in increased susceptibility of dairy cattle to health
disorders, particularly during the transition period (Bernabucci et al., 2005; Sordillo and
Aitken, 2009; Abuelo et al., 2015).
Antioxidant compounds can be synthesized by the body and are also naturally
present in feedstuffs; however, for indoor animals fed low forage diets or especially
during periods of high antioxidant demands such as the peripartal period, dietary
supplementation is necessary to meet increased requirements (NRC, 2001; Spears and
Weiss, 2008; Abuelo et al., 2019). Vitamin E and selenium are the most widely used
antioxidants supplemented in dairy cattle diets, especially in the form of premixes added
to the total mixed ration (Abuelo et al., 2015). However, in the last few decades, there has
been an increased interest in studying alternative natural compounds with antioxidant and
anti-inflammatory properties as feed supplements for food-producing animals (Yang et
al., 2015; Ciampi et al., 2020; Lopreiato et al., 2020). Besides being a potential source of
antioxidants in food consumed by humans, these natural compounds have the added
benefit of being positively perceived by consumers (Abuelo et al., 2019; Bhagat et al.,
2019).
Rosemary (Salvia rosmarinus), an herb from the Labiatae family, is known to
have a particularly high concentration of phenolic diterpenes with antioxidant and
antimicrobial properties (Birtic et al., 2015). Among those phenolic diterpenes, carnosic
acid is the most abundant in rosemary leaves (Luis and Johnson, 2005) and has one of the
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highest antioxidant activities (Cuvelier et al., 1994; Okamura et al., 1994). Carnosic acid
has high reactivity toward ROS and acts as a scavenger that can eliminate ROS (Birtic et
al., 2015). Moreover, carnosic acid plays a role in the activation of the PI3K/Akt/Nrf2
signaling pathway in human cells (de Oliveira et al., 2015; de Oliveira et al., 2016).
Nuclear factor erythroid-2 related factor 2 (Nrf2) is a transcription factor involved in the
cellular response to oxidative stress, inducing the expression of several protective
enzymes, e.g., glutathione peroxidase and superoxide dismutase (de Oliveira et al., 2016).
Furthermore, carnosic acid reduces the expression levels of proinflammatory cytokines in
human and mouse cells (Liu et al., 2019; Hosokawa et al., 2020) and regulates fatty acid
metabolism (Park and Mun, 2013).
However, in ruminants, studies evaluating carnosic acid have been mainly
correlated with an increase in meat quality through reduction of lipid oxidation (Nieto et
al., 2010; Moran et al., 2012; Jordan et al., 2014). Surprisingly, its potential use as a
strategy to reduce the oxidative and metabolic stress of transition dairy cows remains
terra incognita. Based on the above, we hypothesized that providing carnosic acid during
early lactation might minimize the typical exposure to oxidative stress and attenuate the
typical inflammatory response during the peripartum period while allowing cows to reach
peak performance. The objective of the present study was to evaluate the effects of a
compound found in rosemary plants (Salvia rosmarinus) named carnosic acid during the
transition period of dairy cows.
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Materials and methods
Experimental design and treatments
The Institutional Animal Care and Use Committee (IACUC) of the South Dakota
State University approved all the procedures for this study (protocol no. 2003-017A). The
experiment was conducted from September to December 2020 at the South Dakota State
University Dairy Research and Training Facility (Brookings, SD). Twenty late pregnant
multiparous Holstein dairy cows were used in a randomized complete block design from
−21 days prior to expected calving until 21 days in milk (DMI). Cows were blocked
according to expected calving day, parity, and previous lactation milk yield, then
assigned into one of two treatments. A total of 4 cows were removed from the experiment
due to calving outside the range of −7 to 7 d relative to the expected calving date (n = 2),
displaced abomasum (n = 1), and euthanasia due to low calcium/potassium at calving
coupled with a lack of response to treatment (n = 1) (Table 1). Therefore, the number of
experimental animals used for analysis was eight per treatment.
From day 1 to 3 after calving, cows received either a daily intravenous infusion of
500 mL of sterile saline solution (NaCl 0.9%; Saline; n = 8) or an infusion with carnosic
acid at a rate of 0.3 mg/kg of BW (CA; n = 8). The complete dose of carnosic acid
(Combi-Blocks, San Diego, USA, cat. number QC-4383) based on BW was supplied in a
total volume of 500 mL of sterile saline solution. Treatments were infused into the
external jugular vein before evening milking (1700 h).
In rodents, pharmacokinetic studies have been performed using intravenous
infusions with CA at a rate of 10 or 20 mg/kg (Yan et al., 2009; Doolaege et al., 2011).
To the authors’ knowledge, a carnosic acid pharmacokinetic study in ruminants has never
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been performed. Milk is the only body fluid that has been used to detect carnosic acid in
ruminants supplemented with distilled rosemary leaves (Jordan et al., 2010). Jordan et al.
(2010) fed goats a basal diet supplemented with 0, 10, and 20% of the diet with a pellet
containing barley and distilled rosemary leaves and observed a carnosic acid
concentration in milk ranging from 0.31 to 0.77 mg/kg. Therefore, given the limitations
on pharmacokinetic data on carnosic acid in ruminants and the cost of procuring the CA
coupled with the large amount of CA needed to supply the corresponding dose for an
adult dairy cow, a 0.3 mg/kg BW dose was adopted as the most feasible daily dosage
from 1 to 3 d postpartum.
Animal management
Cows were enrolled in the experiment from early September 2020 to early
January 2021. Weather data from Mesonet at South Dakota State University
(https://climate.sdstate.edu/) was used to evaluate the daily ambient temperature during
the experimental period. Cows were fed using an individual gate system (American
Calan, Northwood, NH, USA) and intakes were recorded daily. Diets were formulated
using the Cornell Net Carbohydrate and Protein System (CNCPS) model contained
within the Agricultural Modeling and Training Systems (AMTS) CattlePro diet-balancing
software (version 4.16.1, AMTS LLC, Lansing, NY, USA) to meet the requirements of
the average cow in the group (Table 2). Dry matter content of feed ingredients was
determined once a week throughout the experiment, and diets were adjusted accordingly
to maintain formulated DM ratios.
During the dry period, cows were housed in bedded pack pens. Immediately after
calving, cows were reallocated in individual pens bedded with straw. On day 3, after
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calving, cows were moved to a lactation free-stall barn. Cows were fed once daily (6:00)
and milked twice daily (6:30 and 18:00). Body weight was measured weekly for each
cow in the morning (9:00). Body condition score (BCS) (scale 1 = thin to 5 = obese) was
assigned weekly by two individuals, and the average score was used for statistical
analysis. All cows received the same close-up diet (1.46 Mcal of NEL/kg and 15.1% CP;
Table 2) and lactation basal diet (1.75 Mcal of NEL/kg and 19.6% CP; Table 2), as a total
mixed ration.
Blood collection and analyses
Blood was sampled from the coccygeal vein before morning feeding using a 20gauge vacutainer needle (Becton Dickinson, Franklin Lakes, NJ) at –7, 2, 5, 7, 14, and 21
d relative to parturition. Blood was collected into evacuated tubes (BD Vacutainer,
Becton Dickinson, Franklin Lakes, NJ) containing either serum clot activator or lithium
heparin. After collection, tubes that contained lithium heparin were placed on ice, and
tubes with serum clot activator were kept at 21 °C until centrifugation. Serum and plasma
were obtained by centrifugation at 1,300 × g for 15 min at 21 °C and 4 °C, respectively.
The aliquots were frozen at −80°C until further analysis.
Blood samples were analyzed for biomarkers related to energy metabolism [i.e.,
glucose, β-hydroxybutyric acid (BHB), non-esterified fatty acids (NEFA)], muscle mass
catabolism (i.e., urea and creatinine), inflammation (i.e., ceruloplasmin and haptoglobin),
liver function [i.e., albumin, bilirubin, glutamic-oxaloacetic transaminase (GOT), γglutamyltransferase (GGT), cholesterol, and paraoxonase (PON)], and oxidative stress
[i.e., myeloperoxidase (MPO), reactive oxygen metabolites (ROM), ferric reducing
antioxidant power (FRAP), nitrates (NO3-), nitrites (NO2-), nitric oxide metabolites
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(NOx), and oxygen radical absorbance capacity (ORAC)]. Furthermore, we calculated the
ratios between oxidants and antioxidant defenses, e.g., ROM/FRAP and ROM/ORAC.
Those ratios provide an integrated oxidant status index, which better assesses changes in
oxidative status during the transition period when compared with the biomarkers alone
(Abuelo et al., 2013; Mezzetti et al., 2019b).
Albumin, cholesterol, bilirubin, urea, creatinine, GOT, GGT, and glucose were
analyzed using the IL Test purchased from Instrumentation Laboratory Spa (Werfen Co.,
Milan, Italy) in the ILAB 600 clinical auto-analyzer (Instrumentation Laboratory,
Lexington, MA), following the procedures described previously (Trevisi et al., 2012;
Batistel et al., 2016; Jacometo et al., 2016). Haptoglobin was analyzed using the method
described by Skinner et al. (1991), while ceruloplasmin was determined based on
Sunderman and Nomoto (1970) with modifications described by Jacometo et al. (2015).
Antioxidant potential was assessed as ferric reducing antioxidant power (FRAP) using a
colorimetric method (Benzie and Strain, 1996). Reactive oxygen metabolites (ROM)
were analyzed with the d-ROMs-test (cod. MC002), purchased from Diacron (Grosseto,
Italy). Paraoxonase, NOx, NO2-, and NO3- were analyzed according to methods described
by Trevisi et al. (2013). Myeloperoxidase was determined via colorimetry based on the
reaction of MPO contained in the plasma sample with hydrogen peroxide, which forms
H2O and O−; the O− dianisidine dihydrochloride, and electron donor, reacts with the O−,
releasing H2O and a colored compound, which is then measured (Bionaz et al., 2007;
Jacometo et al., 2015). Non-esterified fatty acids and BHB were measured using kits
from Wako (Chemicals GmbH, Neuss, Germany) and Randox (Randox Laboratories
Ltd., Crumlin, UK), respectively, following the procedures described previously (Bionaz

38

et al., 2007; Trevisi et al., 2012; Osorio et al., 2013). Finally, total antioxidants were
assessed through the oxygen radical absorbance capacity (ORAC) assay. This method
estimates the antioxidant capacity to inhibit phycoerythrin hydroxyl radical damage over
time (Cao and Prior, 1999).
Milk and feed samples
Total mixed ration samples were collected weekly and frozen at −20 °C after DM
analysis until further nutrient profile analysis. Monthly composites were analyzed for
DM, CP, NDF, and ADF contents, while NEL was calculated using wet chemistry
methods at a commercial laboratory (Dairy One; Ithaca, NY, USA).
Consecutive morning and evening milk samples were collected once weekly until
21 DMI. Composite milk samples were performed in proportion to milk yield at each
milking, preserved (Broad Spectrum Microtabs II, Advanced Instruments, Norwood,
MA), and analyzed for fat, protein, lactose, solids, milk urea nitrogen (MUN), and
somatic cell count (SCC) (Dairy One; Ithaca, NY). Energy corrected milk (ECM) was
calculated based on milk yield and milk sample analysis as follows: ECM = (12.82 × fat
yield (kg)) + (7.13 × protein yield (kg)) + (0.323 × milk yield (kg)) (Hutjens, 2010).
Energy balance (EB) for each cow was calculated based on equations described
previously (NRC, 2001). The net energy intake (NEI) was determined based on daily
DMI multiplied by NEL density of the diet, and net energy of maintenance (NEM) was
calculated as BW0.75 × 0.080. Requirements of net energy of lactation (NEL) were
calculated as NEL = (0.0929 × fat % + 0.0547 × protein % + 0.0395 × lactose %) × milk
yield. The net energy requirement for pregnancy (NEP) was calculated as NEP =
[(0.00318 × day of gestation − 0.0352) × (calf birth weight/45)]/0.218. The equation used
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to calculate prepartal EB (EBPRE; Mcal/d) was EBPRE = NEI − (NEM + NEP) and EBPRE (as
% of requirements) = [NEI / (NEM + NEP)] × 100. Finally, to calculate postpartal EB
(EBPOST), the equation used was EBPOST (Mcal/d) = NEI − (NEM + NEL) and EBPOST (as
% of requirements) = [NEI / (NEM + NEL)] × 100.
Phagocytosis capacity, oxidative burst activity, and L-selectin assay
The phagocytosis capacity and oxidative burst activity of peripheral leukocytes
were determined upon challenge with enteropathogenic bacteria (Escherichia coli
0118:H8, kindly donated by M. A. Ballou, Texas Tech University, Lubbock) as
previously described by Hulbert et al. (2011), with modifications. Briefly, blood was
sampled on 21 d relative to calving from the coccygeal vein into evacuated tubes (BD
Vacutainer, Becton Dickinson, Franklin Lakes, NJ) containing lithium heparin. Tubes
were placed on ice and immediately transported to the laboratory for analysis.
Two hundred microliters of whole blood with 40 µL of 100 µM
dihydrorhodamine 123 (Sigma-Aldrich, St. Louis, USA), and 40 µL of propidium iodinelabeled bacteria (109 CFU/mL) were incubated in a warm bath at 38.5°C for 10 min. Red
blood cells were lysed through a sequence of washings with ice-cold deionized water and
5× PBS. After lysing, cells were resuspended in 1× PBS solution and stained for Lselectin, with BAQ92A primary anti-bovine CD62L antibody (Washington State
University, Pullman, USA) and APC-labeled secondary antibody (Biolegend, San Diego,
USA). Lastly, the cells were resuspended in 1× PBS solution for flow cytometry analyses
(Attune™ NxT Flow Cytometer, Thermo Fisher Scientific, Waltham, USA). Data are
reported as percentages of cell phagocytosis, oxidative burst, and L-selectin expression.
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Statistical analysis
The effects of carnosic acid blood biomarkers were evaluated separately at 2 d
relative to parturition (during infusions) and from 5 to 21 d postpartum as residual effects
of CA. Performance data and residual effects were evaluated by repeated measures using
the MIXED procedure of SAS 9.4 (SAS Institute Cary NC, USA). The statistical model
contained the effects of treatment, time (day or week), and their interactions as fixed
effects, while the cow within treatment was considered as a random effect. Single timepoint data were analyzed following the same model, without the time statement. Blood
biomarkers were log-scale transformed if needed to comply with normal distribution of
residuals.
Residual data on blood biomarkers from 5 to 21 d postpartum was unequally
spaced; therefore, the Spatial Power covariance structure was used for this analysis. For
the equally spaced measures, the covariance structure was chosen between first-order
autoregressive and heterogeneous first-order autoregressive based on goodness of fit
(smaller Akaike information criteria). Covariates, including previous 305 d milk yield,
prepartum DMI, ambient temperature, and blood metabolites at –7 d relative to calving,
were maintained in the model when p ≤ 0.20. Observations were considered outliers
when Cook’s distance > 0.50 and consequently excluded from the analysis. The CORR
procedure of SAS was used to test the Pearson correlation coefficient (r) between milk
performance and prepartum DMI, BW prepartum, and change in energy balance. The
occurrence of health problems was analyzed using the FREQ procedure of SAS and
interpreted based on Fisher’s exact test probabilities. However, none of the health issues
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observed in this experiment were affected (p ≥ 0.26) by treatment (Table 1). Statistical
significance was declared at p ≤ 0.05 and tendencies at p ≤ 0.10.
Results
Peripartal DMI, BW, and BCS
Main effects and interactions for prepartum and postpartum BW, BCS, DMI, DMI
as % of BW, and EB are presented in Table 3. Results show a Trt × T interaction (p ≤
0.05) for prepartum DMI as % of BW and EB. However, no differences (p > 0.10) were
observed between treatments at any given time point, and the interaction seems to be
driven by changes in DMI as % of BW and EB from wk −2 to −1 observed for CA cows.
Moreover, CA cows had lower (p = 0.03) postpartum DMI as % of BW, while a trend (p
= 0.06) for greater BW prepartum was observed compared to saline cows. In contrast,
treatment effects (p > 0.10) were not observed for postpartum BW. Body condition score
and DMI were similar (p > 0.10) between treatment groups throughout the experimental
period. Although EB was similar (p > 0.10) between treatments, further analysis showed
that CA cows had a greater (p = 0.04) EB change (𝐸𝐵𝑝𝑟𝑒𝑝𝑎𝑟𝑡𝑢𝑚 − 𝐸𝐵𝑝𝑜𝑠𝑡𝑝𝑎𝑟𝑡𝑢𝑚 ) than
saline cows around parturition (−19.8 vs. −13.8 ± 1.9 Mcal/d).
Milk production and composition
The main effects and interactions for postpartum production variables and milk
composition are presented in Table 4. A trend (p ≤ 0.10) for greater milk yield (Figure 1),
ECM, and milk efficiency as milk/DMI was observed in CA cows in comparison with
saline cows. The CA cows produced 4.5 kg/d and 6.3 kg/d more milk and ECM than
saline cows, respectively. Similar to milk yield, a trend (p = 0.10) was observed for
greater milk protein yield in CA cows when compared to the saline group. Milk yield was
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negatively correlated with energy balance change around parturition (r=−0.63, p = 0.01)
(𝐸𝐵 𝑐ℎ𝑎𝑛𝑔𝑒 = 𝐸𝐵𝑝𝑟𝑒𝑝𝑎𝑟𝑡𝑢𝑚 − 𝐸𝐵𝑝𝑜𝑠𝑡𝑝𝑎𝑟𝑡𝑢𝑚 ). In contrast, milk yield and BW
prepartum were not correlated in either CA (r = −0.24; p = 0.56) or saline (r = 0.27; p =
0.52) cows (Figure 2).
Blood biomarkers
Immunometabolic effects of carnosic acid were evaluated at 2 d relative to
calving and are present in Table 5. The CA cows had lower (p ≤ 0.05) concentrations of
haptoglobin, paraoxonase, FRAP, and NO2− than saline cows, while a trend (p = 0.07)
for lower myeloperoxidase was observed in CA cows compared to saline cows.
Residual effects of treatments on blood biomarkers are shown in Table 6. There
was a Trt × T interaction (p ≤ 0.05) for haptoglobin, where CA cows had lower (p = 0.03)
haptoglobin than saline cows at 5 d relative to parturition (Figure 3). A trend (p = 0.10)
for lower NO3− in CA cows than saline was observed from 5 to 21 d relative to
parturition (Table 6).
Phagocytosis capacity, oxidative burst activity, and L-selectin assays
Main effects for leukocyte phagocytosis capacity, oxidative burst activity, and Lselectin expression at 21 d relative to parturition are presented in Table 7. No differences
(p ≥ 0.10) were observed between treatments in the evaluated parameters.
Discussion
Performance parameters
Antioxidants are frequently part of dairy cows’ diets and play a key role in
minimizing harmful consequences of excessive production of reactive oxygen and
nitrogen species, thereby improving their health status and reducing disease incidence

43

(Abuelo et al., 2015; Sordillo, 2016). Several studies have recently evaluated the effects
of plant-based bioactive compounds with antioxidant properties as alternatives to
conventionally available forms. In terms of animal productivity, performance responses
when supplementing alternative plant-based antioxidants were not consistent among
studies, most likely due to different properties of compounds, doses, animal species,
among other reasons (Oh et al., 2017; Lopreiato et al., 2020). For example, Oh et al.
(2015) observed that oxidative stress markers were not affected when supplementing
lactating dairy cows with Capsicum oleoresin. However, the authors observed increased
ECM and neutrophil activity. In contrast, Mezzetti et al. (2020) reported positive effects
in terms of liver function and redox balance when transition dairy cows were
supplemented with Aloe arborescens; however, milk production was unaffected by
treatment.
In the present study, we observed that carnosic acid infusions increased milk
yield, ECM, and milk protein yield. Moreover, there was no difference in DMI between
treatment groups, which resulted in greater milk efficiency in terms of milk yield/DMI.
Although the effects of carnosic acid in dairy cows remain to be elucidated, dietary
supplementation of rosemary plant (Salvia rosmarinus) to dairy goats and sheep has been
evaluated in terms of performance but with inconsistent results. For instance, studies had
reported an increase in milk yield when small ruminants were fed a diet supplemented
with dried rosemary plant or extract (Chiofalo et al., 2010; Smeti et al., 2015; Kholif et
al., 2017), but this effect was not observed by others (Jordan et al., 2010). These benefits
of dietary rosemary on lactation performance have been mainly associated with
modifications in the ruminal environment by the interaction of compounds in rosemary
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(e.g., carnosic acid) with rumen microbiota (Chiofalo et al., 2010; Smeti et al., 2015;
Kholif et al., 2017). These studies suggest that the phenolic compounds found in
rosemary leaves could inhibit protein degradation in the rumen, affect fatty acid
metabolism during ruminal biohydrogenation, and enhance nutrient digestibility and
ruminal fermentation (Smeti et al., 2015; Kholif et al., 2017). Therefore, a direct
comparison between the effects of dietary rosemary plant or extract and intravenous
infusion of carnosic acid is challenging. However, if further research confirms this effect,
rosemary or rosemary compounds may influence milk yield in ruminants.
The lower DMI as % of BW aligned with greater EB change from pre- to
postpartum observed in CA cows, suggesting a greater lipid mobilization. However, the
difference in EB postpartum did not reach statistical significance (Table 3). In light of
these results, we theorize that carnosic acid may influence liver lipid metabolism in
transition dairy cows. In fact, carnosic acid reduces hepatic lipid accumulation in mice
models through down-regulation of de novo lipogenesis and up-regulation of fatty acid
oxidation signals at the mRNA and protein level, including PPARA (Park and Mun,
2013) and MAPK (Wang et al., 2012).
In transition dairy cows, increased fatty acid catabolism in the liver would induce
transmission of signals towards the brain satiety center, reducing feed intake, as
explained by the hepatic oxidation theory (Allen and Piantoni, 2013). Moreover, in this
scenario, gluconeogenesis may be enhanced due to the higher availability of its
precursors, e.g., pyruvate and oxalacetate. This theory could explain the lower DMI as %
BW and the increase in milk production in CA cows. In fact, biomarkers for energy and
liver function suggest that CA cows were able to cope with increased milk production
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without increased liver damage and risk of health disorders such as ketosis, as evidenced
by BHB concentration, which was similar between groups. However, we emphasize that
the effects on hepatic metabolism here proposed are largely speculatory, and further
studies are necessary to determine the specific mechanisms of how hepatocytes respond
to carnosic acid under a peripartal condition in dairy cows.
Inflammation and liver function
Haptoglobin is a positive acute phase protein (APP) synthesized mainly by
hepatocytes during an inflammatory process (Eckersall and Bell, 2010; Ceciliani et al.,
2012). Higher haptoglobin concentrations are related to increased levels of
proinflammatory cytokines, such as tumor necrosis factor alpha (TNFα), IL-1, and IL-6
(Bionaz et al., 2007). In dairy cows, haptoglobin levels are commonly increased during
peripartum, with peak concentrations around the first week of lactation (Bionaz et al.,
2007). This protein is a highly sensitive indicator of immune system activation and, as
such, is a reliable biomarker of stress (Ceciliani et al., 2012; Bertoni and Trevisi, 2013).
Additionally, haptoglobin is a major hemoglobin binding protein, limiting oxidative
tissue damage mediated by hemoglobin. The induction of haptoglobin typically
associated with enhanced oxidative stress seems to be a mechanism to prevent excessive
damage caused by free radicals (Bertaggia et al., 2014).
In the present study, we observed a treatment effect on haptoglobin concentrations
between the days of infusion (2 d) until 5 d relative to parturition (Table 5 and Figure 3,
respectively). Several studies have observed the anti-inflammatory effects of carnosic
acid (Oh et al., 2012; de Oliveira et al., 2018; Hosokawa et al., 2020). This phenolic
diterpene significantly decreased the protein expression levels of various
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proinflammatory cytokines in serum and tissues, e.g., TNFα, IL-1β, and IL-6 (Liu et al.,
2019), through the suppression of the jun-N-terminal kinase (JNK), nuclear factor κB
(NF-κB) and signal transducer and activator of transcription 3 (STAT3) pathways (Song
et al., 2018; Hosokawa et al., 2020). Concentrations of haptoglobin in the days following
calving observed in our study suggest a lower inflammatory status in CA cows, which
agrees with previous studies using different animal models (Lopreiato et al., 2020).
Haptoglobin and PON are APP produced mainly by the liver. However, while
haptoglobin is a positive APP, PON is characterized as a negative APP, meaning its
hepatic synthesis is impaired during inflammation (Bionaz et al., 2007; Bertoni and
Trevisi, 2013). In the plasma, PON is transported in association with high-density
lipoproteins, and it exerts an important antioxidant function by hydrolyzing lipid
hydroperoxides generated during oxidative stress (Turk et al., 2004; Turk et al., 2005).
Moreover, decreased PON activity following parturition, especially in high producing
dairy cows, is associated with intense lipomobilization and fat deposition in hepatocytes,
related to liver damage or dysfunction (Turk et al., 2004).
In the present study, lower concentrations of PON were observed for CA cows
than saline cows at 2 d relative to parturition (58 vs 67 U/mL). However, there was no
difference between treatments from 5 to 21 d (83.1 vs 92.1 ± 5.3 U/mL). The reduction of
PON activity at 2 d relative to parturition could be an indication of increased
inflammation, intense lipomobilization, reduced levels of blood HDL, oxidative stress, or
a combination of those (Bionaz et al., 2007). However, literature suggests that, regardless
of treatment, PON activity observed throughout our study was higher than PON activity
associated with impaired liver function or adverse health conditions after parturition
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(Bionaz et al., 2007; Ceciliani et al., 2012). For example, Bionaz et al. (2007) evaluated
the relationship between PON activity during the first month of lactation with health
problems, inflammatory conditions, and liver function. Cows classified as lower quartile
(43.8 ± 12.7 U/mL) based on PON activity presented lower milk yield, higher blood
ROM, and greater occurrence of serious infections when compared with cows in the
upper quartile (92.0 ± 19.8 U/mL).
In addition to blood biomarkers, immunological function and activation were
evaluated through oxidative burst, phagocytosis, and L-selectin expression at 21 d
relative to parturition. L-selectin is an important adhesion protein expressed on the
surface of neutrophils and other leukocytes, being essential for the adhesion and rolling
of immune cells across the endothelium (Kimura et al., 1999; Aleri et al., 2016). The
expression of L-selectin on the surface of neutrophils decreased at calving, likely due to
the immunosuppressive effects of glucocorticoids, but to recover within 1 to 3 d after
parturition (Kimura et al., 1999; Sordillo, 2016; LeBlanc, 2020).
Furthermore, according to LeBlanc (2020), phagocytosis and oxidative burst are
the two best-studied elements of neutrophil function, the first being the engulfing of
invading microorganisms and the second an oxidative mechanism in which reactive
oxygen metabolites are produced to destroy the ingested invading pathogen (Ingvartsen
and Moyes, 2013). Along with decreased L-selectin expression, neutrophils exhibit
impaired phagocytosis and oxidative burst activity around parturition (Sordillo and
Streicher, 2002), which further contributes to the increased risk of infectious diseases
during this period (Lopreiato et al., 2020). Our results showed no residual effects of CA
on leukocyte function and activation at 21 d relative to calving. Regardless of treatment,
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phagocytosis activity was lower and oxidative burst greater than reported by Zhou et al.
(2016) and Batistel et al. (2018) around the third week of lactation. In agreement with the
present results, Wu et al. (2017) also observed low percentages of neutrophil
phagocytosis against E. coli (< 10%) from 28 d before to 28 d after calving. Moreover,
our results regarding the other biomarkers for liver function support the idea that carnosic
acid infusion from 1 to 3 d relative to parturition did not negatively affect the liver of the
experimental animals.
Oxidative stress
Around 2 d relative to parturition, we also observed a treatment effect on plasma
MPO, in which CA cows had lower concentrations than saline cows. MPO is a lysosomal
peroxidase enzyme mainly stored in the azurophilic granules of neutrophils and to a
lesser degree in primary lysosomes of monocytes (Depreester et al., 2017; Aratani, 2018).
Upon immune cell activation, the enzyme is released extracellularly and into phagosomal
compartments. In the presence of H2O2 and a halide (chloride, bromide, or thiocyanate),
MPO catalyzes the formation of reactive oxygen intermediates, including hypochlorous
acid (HOCl) (Rayner et al., 2014; Aratani, 2018). MPO is an important component of the
host innate immune system against invading microorganisms. Thus it has been used as an
inflammation biomarker (Depreester et al., 2017).
Reactive oxygen species produced by MPO have been implicated as mediators of
host oxidative tissue damage and cellular dysfunction (Depreester et al., 2017; Aratani,
2018). Our results agree with previous studies, which observed an effect of carnosic acid
on decreasing the activity of MPO in mice immune cells during acute lung injury (Li et
al., 2019) and acute colitis (Yang et al., 2017). According to these studies, carnosic acid
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may attenuate oxidative stress by suppressing the production of proinflammatory
cytokines, immune cells activation, and migration. Lower levels of MPO aligned with
haptoglobin results, suggesting lower inflammation in CA cows than saline cows around
the days of CA infusion.
In contrast with our initial hypothesis, blood ROM was not affected by treatment.
These results contrast with previous in vitro studies that observed a lower accumulation
of ROS when different cell lines were treated with carnosic acid (Liu and Dong, 2017;
Peng et al., 2020; Lee and Jang, 2021). de Oliveira et al. (2015) found lower ROS
concentrations when neuroblastoma cells were treated with carnosic acid during induced
neurotoxicity. However, the authors observed no differences when cells were not
challenged. Overall, literature suggests that the effect of carnosic acid on the production
of reactive oxygen compounds might be dose-dependent, and cellular conditions may
have an important role in its effectiveness. Alternatively, the lack of effect on ROM due
to CA infusion could be attributed to CA attenuating ROS production at a phagocytic cell
level, but not sufficient to affect ROS being produced during the high metabolic state at
the onset of lactation. Moreover, the limitation of in vivo experiments, especially in
ruminants, makes it particularly challenging to correlate our findings with a specific
biological mechanism.
The high complexity of the oxidant defense system and dynamics between
prooxidants and antioxidants among different tissues makes it challenging to quantify and
infer the overall whole-organism redox balance accurately. The individual quantification
of specific antioxidants does not provide a complete picture of the antioxidant capacity in
a given sample since multiple mechanisms act synergically to counterbalance oxidative
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stress (Benzie and Strain, 1996; Abuelo et al., 2015). In this context, different analytic
methods, i.e., FRAP and ORAC, were developed to estimate antioxidant activity of a
certain sample. An increase in FRAP plasma values indicates a greater need for
neutralizing ROM production, while higher ORAC denotes greater protection produced
by antioxidants in plasma (Batistel et al., 2016).
The CA cows had a lower FRAP at 2 d relative to parturition when compared to
saline cows. However, no differences were observed for ORAC, ROM/FRAP, or
ROM/ORAC. Plasma concentrations of carnosic acid declined rapidly after CA
intravenous infusion in rats, while gastrointestinal absorption results in longer plasma CA
retention (Yan et al., 2009; Doolaege et al., 2011). In the present study, blood samples
were collected around 12 h after intravenous infusions, which might help explain why
plasma antioxidant activity and oxidative status were mostly unaffected by carnosic
treatment. Furthermore, studies with carnosic acid in ruminant species are scarce, and the
effects of its supplementation on plasma FRAP or ORAC are currently unknown. Jordan
et al. (2014) evaluated the level of transfer of two typified rosemary extracts (carnosic
acid and carnosol) in lamb tissues after dietary supplementation. Carnosic acid, especially
at 1:1 ratio with carnosol, increased muscle and liver FRAP, although plasma FRAP was
not evaluated in that study.
Carnosic acid treatment reduced levels of NO2- around the period of infusions (2
d postpartum). Moreover, a residual effect of treatment was observed in terms of NO3from 5 to 21 d relative to parturition. Nitrite (NO2−) and nitrate (NO3−) are stable
products of nitric oxide (NO), and the measurement of these oxidation products is used to
estimate NO production in biological fluids (Levine et al., 1998; Batistel et al., 2016).
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Nitric oxide is an important free radical synthesized by immune and endothelial cells; it is
involved in many biological functions, including intracellular communication,
vasodilatation, and inflammation (Burner et al., 2000; Tripathi et al., 2007; Nash et al.,
2012). At physiological levels, its toxicity is generally limited (Nash et al., 2012).
However, at high concentrations, NO is rapidly oxidized to reactive nitrogen oxide
species (RNOS), e.g., nitrogen dioxide (NO2) and dinitrogen trioxide (N2O3), which in
turn induce cell toxicity through modification of enzymes, signaling proteins, and
transcription factors (Coleman, 2001). Studies have observed decreased levels of NO in
the presence of carnosic acid, which was associated with lower levels of the inducible
NO synthase enzyme (iNOS) (Hou et al., 2012; Oh et al., 2012). Overall, our results
indicate that carnosic acid may have decreased NO synthesis, suggesting lower
inflammation and a lower risk of oxidative damage.
Conclusions
The findings of this study revealed that carnosic acid reduced inflammation and
oxidative stress biomarkers around the period of CA infusion. In addition, carnosic acid
contributed to an increase in lactation performance, although the mechanisms responsible
for this response remain unclear. Pharmacokinetics studies are necessary to further
understand how carnosic acid is metabolized in ruminants and how fast metabolism
occurs to estimate optimal dosage and carnosic acid supplementation through its plantbased source, rosemary. Overall, the results presented here describe the potential benefits
of providing antioxidants such as carnosic acid during the peripartal period of dairy cows.
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Table 2.1. Frequency of occurrence of health problems in peripartum dairy cows receiving
an intravenous infusion of carnosic acid (CA) or saline (Saline) from -21 relative to
parturition through 21 DIM.
Treatment
Event

1

CA

Saline

Total animals

10

10

Subclinical ketosis1

5

4

Clinical ketosis2

0

2

Retained placenta3

0

1

Displaced abomasum

0

1

Metritis4

1

0

Pneumonia

1

0

Total excluded cows5

2

2

Defined as cows having 1.4 to 2.9 mmol/L ketone concentration in blood, detected
using a Precision Xtra analyzer (Abbott Labs). Treatment administrated was oral
propylene glycol and injection of vitamin B complex.
2
Defined as cows having > 2.9 mmol/L ketone concentration in blood, detected using a
Precision Xtra analyzer (Abbott Labs). Treatment administrated was oral propylene
glycol and injection of vitamin B complex.
3
Defined as fetal membranes retained > 24 h postpartum.
4
Foul-smelling, watery-consistency uterine discharge after calving.
5
Cows excluded from the experiment due to calving outside the range of −7 to 7 d
relative to the expected calving date (CA, n = 1; Saline, n = 1), displaced abomasum
(Saline, DIM = 18, n = 1), euthanasia due to low calcium/potassium at calving coupled
with a lack of response to treatment (CA, DIM = 0, n = 1).
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Table 2.2. Ingredient composition of diets during the close-up (−21 d to expected calving)
and early lactation periods (21 d relative to calving).
Diet
Component
Ingredient, % of DM
Corn silage
Alfalfa hay
Alfalfa haylage
Grass hay
Wheat straw
Soybean meal
Cottonseed
Molasses
Dry cow grain mix1
Lactating cow grain mix2
Chemical analysis
DM, %
NEL, Mcal/ kg DM
CP, % DM
NDF, % DM
ADF, % DM
Starch, % DM
DCAD, mEq/100 g
1

Close-up

Lactation

36.9
24.6

32.5
7.6
12.1
-

12.4
11.5
14.6
-

5.7
6.7
5.0
30.4

46.7
1.46
15.1

47.6
1.75
19.6

43.7
27.4
15.9
−12.3

31.8
17.7
28.2
-

Dry cow grain mix contained (as % DM): distillers grain dry (24.8), soy hulls (21.4),
biochlor (18.5), limestone Ca (14.0), magnesium sulfate 7H2O (3.5), calcium phosphate
21% (3.5), reashure choline (2.8), calcium chloride dihydrate (2.3), magnesium oxide
54% (2.3), calcium sulfate dihydrate (1.5), chromium propionate 0.04% (1.0), DV
nutritek (0.9), JPW dairy vitamin premix 8298.V05 (0.9), salt white (0.7), vitamin E
20000 IU/lb (0.7), JPW dairy TM premix 8298.E04 (0.7), DTX binder (0.4), rumensin 90
g/lb (0.1).
2
Lactating cow grain mix contained (as % DM): corn grain ground fine (66.1), soy best
(14.8), distillers grain dry (7.4), limestone Ca (2.7), sodium bicarbonate (2.8), energy
booster 100 (2.2), salt white (1.16), urea (0.90), magnesium oxide 54% (0.55), calcium
phosphate 21% (0.33), JPW dairy vitamin premix 8298.V05 (0.29), JPW dairy TM
premix 8298.E04 (0.29), DV nutritek (0.22), vitamin E 20000 IU/lb (0.11), DTX binder
(0.11), rumensin 90 g/lb (0.02), biotin 1% (0.02).
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Table 2.3. Differences between treatment groups during prepartum and main residual
effects of intravenous infusion of carnosic acid (CA) or saline solution (Saline) on BW,
BCS, DMI, DMI as % of BW, and energy balance.
Treatment
CA
Saline

SEM1

Trt

p-Value
Time Trt × T2

Parameter
Prepartum
Body weight, kg
Body condition score
Dry matter intake, kg/d
Dry matter intake, % BW

873.3
3.70
15.3
1.73

801.6
3.75
13.2
1.69

25.0
0.08
0.92
0.13

0.06
0.65
0.12
0.82

0.01
0.74
<0.01
<0.01

0.34
0.24
0.41
0.04

Energy balance, Mcal/d

6.10

4.49

1.56

0.47

<0.01

0.05

Postpartum
Body weight, kg
Body condition score
BW change3, %
BCS change3, %
Dry matter intake, kg/d
Dry matter intake, % BW
Energy balance, Mcal/d

735.5
3.55
−13.0
−4.8
18.6
2.48
−13.51

739.9
3.54
−11.6
−5.2
20.2
2.85
−9.53

7.64
0.04
0.92
1.06
0.72
0.11
1.82

0.71
0.88
0.33
0.77
0.15
0.03
0.14

<0.01
<0.01
<0.01
<0.01
<0.01
<0.01
0.02

0.19
0.13
0.22
0.26
0.70
0.33
0.19

1

Largest standard error of the mean.
Interaction of treatment and time (day or week) relative to calving.
3
Percent change from the average of 3 weeks prepartum.
2
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Table 2.4. Main residual effects of intravenous infusion of carnosic acid (CA) or saline
solution (Saline) on milk production and composition parameters during 21 d in milk.

Parameter
Milk yield, kg/d
Energy corrected milk3, kg/d
Milk efficiency, Milk/DMI4
Milk efficiency, ECM/DMI
Milk Composition
Fat, %
Fat yield, kg/d
Protein, %
Protein yield, kg/d
Lactose, %
Solids, %
Milk urea nitrogen, mg/dL
Log-transformed SCC5
1

Treatment
CA
Saline
41.8
37.3
51.3
45.0
2.37
2.04
2.75
2.47
5.07
2.11
3.52
1.45
4.69
14.35
12.71
4.93

5.26
1.89
3.53
1.27
4.74
14.62
12.19
5.11

SEM1
1.76
2.35
0.12
0.17

Trt
0.10
0.08
0.06
0.25

0.23
0.12
0.14
0.07
0.05
0.25
0.92
0.14

0.56
0.19
0.96
0.10
0.49
0.47
0.70
0.40

p-Value
Time Trt × T2
<0.01
0.35
<0.01
0.95
0.02
0.56
0.03
0.11
<0.01
0.13
<0.01
0.18
<0.01
<0.01
0.73
0.08

0.78
0.82
0.60
0.93
0.56
0.70
0.88
0.79

Largest standard error of the mean.
Interaction of treatment and time (day or week) relative to calving.
3
Energy corrected milk (ECM), calculated as [12.82 × fat yield (kg)] + [7.13 × protein
yield (kg)] + [0.323 × milk yield (kg)]; 4 DMI: dry matter intake; 5 SCC: somatic cell
count.
2
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Table 2.5. Effects of intravenous infusion of carnosic acid (CA) or saline solution (Saline)
on blood biomarkers related to energy metabolism, inflammation, liver function, muscle
body mass, metabolism, and oxidative stress in dairy cows at 2 d relative to parturition.

Parameter
Energy metabolites
Glucose, mmol/L
BHB, mmol/L
NEFA, mmol/L
Inflammation
Ceruloplasmin, µmol/L
Haptoglobin2, g/L
Liver function
Albumin, g/L
Cholesterol, mmol/L
Paraoxonase, U/mL
Bilirubin2, µmol/L
AST, U/L
GGT2, U/L
Muscle mass catabolism
Urea, mmol/L
Creatinine, µmol/L
Oxidative stress
FRAP 2 , µmol/L
Myeloperoxidase, U/L
ROM, mg H2O2/100mL
NO2–, µmol/L
NO3–, µmol/L
NOx, µmol/L

Treatment
CA
Saline

SEM1

p-Value
Trt

4.10
0.83
0.83

4.03
0.82
0.65

0.11
0.12
0.13

0.68
0.98
0.35

2.30
0.67

2.41
1.06

0.07
0.16

0.38
<0.01

33.46
1.74
58.03
5.17
119.9
17.39

33.97
1.84
67.38
5.21
105.3
16.34

0.49
0.09
2.61
0.42
8.20
0.09

0.48
0.42
0.03
0.99
0.23
0.48

5.39
94.25

5.28
88.27

0.27
2.97

0.80
0.21

140.1
485.3
15.88
2.63
21.85
23.9

163.1
519.6
16.73
4.58
19.62
23.65

0.06
12.8
0.52
0.35
1.13
0.87

0.02
0.07
0.28
<0.01
0.19
0.84

ORAC, µg/mL
12.50
13.06
0.34
0.25
ROM/FRAP
0.11
0.10
0.01
0.44
ROM/ORAC
1.25
1.32
0.06
0.40
1
Largest standard error of the mean.
2
Data were log-transformed before statistics. The standard errors of the means associated
with log-transformed data are in log scale.

57

Table 2.6. Residual effects of intravenous infusion of carnosic acid (CA) or saline solution
(Saline) on blood biomarkers related to energy metabolism, inflammation, liver function,
muscle body mass, metabolism, and oxidative stress in dairy cows from 5 to 21 d.

Parameter
Energy metabolites
Glucose, mmol/L
BHB, mmol/L
NEFA, mmol/L
Inflammation
Ceruloplasmin, µmol/L
Haptoglobin2, g/L
Liver function
Albumin, g/L
Cholesterol, mmol/L
Paraoxonase, U/mL
Bilirubin2, µmol/L
AST, U/L
GGT2, U/L
Muscle mass catabolism
Urea, mmol/L
Creatinine, µmol/L
Oxidative stress
FRAP 2 , µmol/L
Myeloperoxidase, U/L
ROM, mg H2O2/100mL
NO2–, µmol/L
NO3–, µmol/L
NOx, µmol/L

Treatment
CA
Saline

SEM1

Trt

p-Value
Time Trt × T3

3.87
1.06
0.63

4.02
0.99
0.63

0.08
0.21
0.09

0.20
0.83
0.99

0.03
0.73
<0.01

0.88
0.90
0.88

2.88
0.44

2.99
0.44

0.12
0.17

0.55
0.99

0.28
0.14

0.90
0.04

35.51
2.92
83.08
3.46
149.2
23.92

34.71
3.11
92.07
3.66
122.9
20.25

0.33
0.13
5.33
0.20
13.43
0.16

0.11
0.31
0.25
0.78
0.19
0.32

0.03
<0.01
0.10
<0.01
0.21
0.06

0.53
0.37
0.79
0.79
0.34
0.40

5.01
84.83

5.06
82.35

0.23
1.42

0.87
0.25

0.37
<0.01

0.51
0.71

128.0
447.4
17.61
5.78
21.71
28.25

132.5
436.1
18.40
5.90
23.07
28.21

0.09
19.9
0.69
0.42
0.58
0.72

0.71
0.70
0.44
0.85
0.10
0.97

<0.01
0.01
0.10
<0.01
0.01
<0.01

0.12
0.95
0.35
0.92
0.91
0.96

ORAC, µg/mL
12.56 12.23
0.58
0.70
0.95
0.97
ROM/FRAP
0.14
0.15
0.01
0.86
<0.01
0.69
ROM/ORAC
1.48
1.56
0.09
0.53
0.74
0.56
1
Largest standard error of the mean.
2
Data were log-transformed before statistics. The standard errors of the means associated
with log-transformed data are in log scale.
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3

Interaction of treatment and days relative to calving.
Table 2.7. Residual effects of intravenous infusion of carnosic acid (CA) or saline
solution (Saline) on leukocyte phagocytosis capacity, oxidative burst activity, and Lselectin at 21 d relative to parturition.

Parameter
Phagocytosis, %
L-selectin, %
Oxidative burst, %
1

Treatment
CA
Saline
9.34
8.97
67.0
71.7
88.0
85.3

Largest standard error of the mean.

SEM1
1.16
6.55
2.33

p-Value
Trt
0.82
0.63
0.41

60
55
50
45
40
35
30
25
20
15
10

A

TRT, p = 0.10
Time, p < 0.01
Trt × Time, p = 0.35

CA
Saline
0

3

6

9

12

15

18

Day relative to parturition

21

Energy corrected milk (kg/d)

Milk yield (kg/d)

59

60
55

B

TRT, p = 0.08
Time, p < 0.01
Trt × Time, p = 0.95

50
45
40
35
1

2

3

Week relative to parturition

Figure 2.1. Milk yield (A) and energy corrected milk (B) for peripartal dairy cows infused from 1 to 3 d postpartum with 500
mL of sterile saline solution (Saline) or carnosic acid (CA) at a rate of 0.3 mg/kg BW supplied in a total volume of 500 mL of
saline. Values are means, and the standard errors are represented by vertical bars.
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Figure 2.2. Correlation between body weight prepartum and milk yield for peripartal dairy
cows infused with 500 mL of sterile saline or carnosic acid at a rate of 0.3 mg/kg BW
supplied in a total volume of 500 mL of sterile saline solution.
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Figure 2.3. Residual effects of carnosic acid (CA) or saline intravenous infusions on blood
biomarkers from 5 to 21 d relative to parturition for haptoglobin. Mean separations between
treatments at a given time point were evaluated at a treatment × time interaction (p ≤ 0.10),
and differences (*) were declared at p ≤ 0.05. Values are means and the standard errors are
represented by vertical bars.
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CHAPTER 3. EFFECTS OF CARNOSIC ACID ON HEPATOCYTES
SUBJECTED TO HYDROGEN PEROXIDE-INDUCED OXIDATIVE CELL
DAMAGE IN VITRO
Abstract
The objectives of this study were to investigate the oxidative damaging effects of
hydrogen peroxide (H2O2) on alpha mouse liver 12 (AML12) cell line in vitro, determine
whether CA has a cytoprotective effect on AML12 during induced oxidative stress, and
study the underlying mechanisms by which CA can affect the liver in a mouse model.
The AML12 cells were cultured in medium containing three different concentrations of
CA for 12 h, followed by another 12 h incubation with H2O2, which was used to stimulate
oxidative stress in vitro. Specific treatments were (i) control (culture medium without any
treatment), (ii) H2O2 (500 µM), (iii) carnosic acid 3.0 mg/L + 500 µM H2O2, (iv) CA 6.0
mg/L + 500 µM H2O2, and (v) CA 9.0 mg/L + 500 µM H2O2. AML12 viability,
production of ROS, and the activity of superoxide dismutase (SOD) and glutathione
peroxidase (GPx) were measured. We observed a trend of a treatment effect on viability.
In comparison with control, hydrogen peroxide reduced cells viability in all the
treatments, except for CA 9.0 mg/L + 500 µM H2O2, which did not differ from control.
Contrary to our initial hypothesis, CA treatment did not affect intracellular ROS
production. Although no effect of treatments was observed on glutathione peroxidase
activity, superoxide dismutase activity was positively affected by treatment. Moreover,
CA increased superoxide dismutase activity linearly, indicating a dose-dependent
response to CA. Results from this study indicate that carnosic acid supplementation
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might be beneficial in periods of redox balance alterations in vivo, although further
studies are necessary to determine dose-dependent responses and safety levels.
Keywords: AML12; oxidative stress; carnosic acid
Introduction
Oxidative stress is a metabolic condition that can be defined as the damage
occurring to cellular macromolecules as a consequence of a serious imbalance between
oxidants and antioxidants molecules (Halliwell, 2007a; Mavangira and Sordillo, 2018).
Oxidative damage has negative effects, especially on lipids, proteins, and DNA, and has
been associated with the development of several pathologies in various animal species,
including dairy cows (Sordillo and Aitken, 2009; Turk, 2017) and humans (Taniyama and
Griendling, 2003; Pizzino et al., 2017).
In dairy cows, oxidative stress is among the most critical challenges faced around
parturition (Ma et al., 2019). During this period, cows undergo a shift from a gestational
nonlactating state to a state of copious milk synthesis and secretion, demanding metabolic
adjustments to address the dramatic increase in energy requirements (Sordillo and
Raphael, 2013), which leads to an increase in oxygen requirements and the consequent
production of oxidants (Sordillo and Aitken, 2009; Abuelo et al., 2015; Abuelo et al.,
2016a). In parallel, the proinflammatory state of the transition cow leads to the release of
proinflammatory cytokines, which can further induce ROS production by both
phagocytic and non-phagocytic cells (Abuelo et al., 2015), increasing the alteration in
redox balance.
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One of the most important aspects of oxidative stress in transition dairy cows is
negative energy balance (NEB) and the following increase in blood concentration of nonesterified fatty acids (NEFA). Blood NEFA starts to rise 2 to 3 wk before calving, peaks
around parturition or at the first week post-partum (Ingvartsen and Andersen, 2000), and
as NEFA increases, so does their uptake by the hepatic tissue (Busato and Bionaz, 2020).
When used as an energy substrate, NEFA enhance ROS production during βoxidation (Schonfeld and Wojtczak, 2008; Abuelo et al., 2015). The subsequent alteration
in redox balance may lead to insulin resistance in peripheral tissues, which further
increases lipolysis and NEFA levels (Sordillo and Raphael, 2013; Hurrle and Hsu, 2017;
Youssef and El-Ashker, 2017). In fact, the exposure of hepatocytes in culture to
pathologically increased fatty acids levels have been shown to induce mitochondrial
dysfunction and increase cellular ROS content (Gao et al., 2018). According to Schonfeld
and Wojtczak (2008), within the cell, ROS production from fatty acids occurs mostly in
the mitochondria through the respiratory chain, and in the plasma membrane, through
NADPH oxidase.
During periods of high antioxidant demands such as the peripartal period, dietary
supplementation with antioxidants is necessary to meet increased requirements (NRC,
2001; Spears and Weiss, 2008; Abuelo et al., 2019). Vitamin E and selenium are the most
widely used antioxidants included in dairy cattle diets (Abuelo et al., 2015); however, in
the last few decades, there has been an increased interest in studying alternative natural
compounds with antioxidant and anti-inflammatory properties as supplements for foodproducing animals (Yang et al., 2015; Ciampi et al., 2020; Lopreiato et al., 2020). Among
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those alternative sources of antioxidants are polyphenol compounds, which encompass a
family of 500 different phytochemicals and present potential therapeutic applications due
to their intrinsic antioxidative and anti-inflammatory properties (Ballou et al., 2019;
Lopreiato et al., 2020). The polyphenol compound carnosic acid (CA) is a phenolic
diterpene found in herbs from the Labiatae family, especially common salvia (Salvia
officinalis) and rosemary (Salvia rosmarinus) and has antioxidant and antimicrobial
properties (Birtic et al., 2015; Loussouarn et al., 2017).
Carnosic acid has been demonstrated to play a role in oxidative stress response by
the activation of the PI3K/Akt/NRF2 signaling pathway in human cells (de Oliveira et al.,
2015; de Oliveira et al., 2016) and to reduce inflammation in human and mouse cells
through the NF-κB signaling pathway (Liu et al., 2019; Hosokawa et al., 2020). Costa et
al. (2007) observed a dose-dependent protective effect of CA (10, 20, and 30 µM) on Hep
G2 cells exposed to aﬂatoxin B1. Furthermore, CA at 1 μM protects against oxidative
stress-induced cytotoxicity in primary hepatocytes and AML12 cells (Wang and
Takikawa, 2016). In contrast, Dickmann et al. (2012) observed a dose-dependent increase
in hepatotoxicity caused by CA (0.5 to 2.5 µM) in three human hepatocyte donors, but
without a concurrent increase in the apoptosis markers caspase-3/7.
Using mouse liver as a biological model, we hypothesized that CA would have a
protective effect on cultured cells subjected to hydrogen peroxide-induced oxidative
damage. The objectives of this study were to (a) investigate the oxidative damaging
effects of hydrogen peroxide (H2O2) on the alpha mouse liver 12 (AML12) cell line in
vitro, (b) determine whether CA has a cytoprotective effect on AML12 during induced
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oxidative stress, and (3) study the underlying mechanisms by which CA can affect the
liver in a mouse model.
Materials and methods
Cell culture and treatments
The AML12 (alpha mouse liver 12) cell line was purchased from the American
Type Culture Collection (ATCC, Manassas, Virginia, USA) and maintained in
DMEM:F12 base medium (catalog number 11320033, Gibco, Amarillo, Texas, USA)
supplemented with 10% fetal bovine serum, 20 µg/mL of insulin, 5.5 ug/mL transferrin, 5
ng/mL selenium, and 40 ng/mL dexamethasone at 37∘C and 5% CO2 in a humidified
incubator. Cells were revived from liquid nitrogen and after thawing, AML12 were
cultured in 75cm² cell culture flasks. Cells were detached with trypsin 0.05% at 70 to
80% of confluence to perform the assays. Trypan blue exclusion was used to evaluate cell
death. Cells were collected using trypsin, diluted 1:1 in trypan blue, and counted on a
hemocytometer (Countess® II FL Automated Cell Counter, Life Technologies, Carlsbad,
California, USA) to obtain the number of viable cells.
Carnosic acid (95% purity) was purchased at Combi-Blocks (San Diego, USA,
catalog number QC-4383). Carnosic acid was primarily diluted to 0.5 mg/mL with
molecular ethanol, then successively diluted at the time of challenge to reach the
concentrations of 3, 6, and 9 mg/L with cell culture medium. The tested concentration of
carnosic acid in the present study was chosen on the basis of previous results of Jordan et
al. (2010). Those authors observed a carnosic acid concentration of 6.17 ± 0.62 mg/L in
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plasma of sucking goat kids in which the dams were fed a basal diet with a 10% inclusion
rate of distilled aromatic rosemary leaves.
For the cell treatment, indicated concentrations of carnosic acid were applied to
the cells for 12 h. Following pretreatments, to establish in vitro oxidative stress, cells
were incubated with H2O2 as previously described (Jin et al., 2016; Ma et al., 2019).
Briefly, 30% H2O2 was diluted to 1 M stock using sterilized 1×PBS (100 𝜇L 30% H2O2
was diluted with 870.3 𝜇L 1×PBS). Hydrogen peroxide at 1M was further diluted with
cell culture medium to 500 µM and then added into culture plates and incubated for 12 h.
Hydrogen peroxide solutions were made fresh before use. The tested concentration and
time of incubation of H2O2 in the present study were chosen based on previous studies
(Jin et al., 2016; Ma et al., 2018; Ma et al., 2019). Specific treatments were (i) control
(culture medium without any treatment), (ii) H2O2 (500 µM), (iii) carnosic acid 3.0 mg/L
+ 500 µM H2O2, (iv) CA 6.0 mg/L + 500 µM H2O2, and (v) CA 9.0 mg/L + 500 µM H2O2.
Cell viability, production of ROS, and the activity of superoxide dismutase (SOD) and
glutathione peroxidase (GPx) were measured.
Cell viability
Cells were plated at a concentration of 1 x 105 cells/mL in a 96-well plate and
allowed to culture for 24 h before starting the experiment. Carnosic treatments and
hydrogen peroxide-induced oxidative cell damage were applied as described above. The
viability of AML12 was measured using the CellTiter-Glo 2.0 Cell Viability Assay
(Promega Corporation Madison, Wisconsin, USA).
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The method is based on cell lysis followed by generation and quantification of a
luminescent signal proportional to the amount of ATP present, which indicates the
presence of metabolically active cells. The assay has as a principle the mono-oxygenation
of luciferin, catalyzed by luciferase in the presence of Mg2+, molecular oxygen, and ATP,
which is contributed by viable cells. Briefly, 96-well plates and reagents were cooled to
room temperature before beginning the assay. The medium was removed from wells, and
cells were washed with 1×PBS. Following washing, 100 µL of Opti-MEM media
(catalog number 11058021, Gibco, Amarillo, Texas, USA) and 100 µL of CellTiter-Glo
2.0 reagent were added to each well. To induce cell lysis, the 96-well plate was mixed at
200 rpm for 5 min using an incubator shaker (BenchTop Lab Systems, Saint Lois, MO,
USA). The plate was incubated at room temperature for an additional 25 min to stabilize
the luminescent signal. Luminescence was measured using a Synergy 2 Multi-Detection
Microplate Reader (BioTek Instruments, Inc., Winooski, VT, USA).
Intracellular ROS production
Cells were plated at a concentration of 1 x 105 cells/mL in a 96-well plate and
allowed to culture for 24 h before starting the experiment. Treatments were applied as
described above. The intracellular ROS production was measured with Reactive Oxygen
Species (ROS) Detection Assay Kit (BioVision Inc., Milpitas, CA, USA). The assay is
based on the presence of a cell-permeable fluorogenic probe. The oxidation of this
fluorogenic probe by intracellular ROS yields a highly fluorescent product. The
fluorescence intensity is proportional to the ROS levels.
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Briefly, following treatments and hydrogen peroxide-induced oxidative cell
damage, media was removed, and adherent cells were washed with 100 µL of ROS Assay
Buffer. Then, 100 μl of 1X ROS label diluted in ROS Assay Buffer were added to each
well. Cells were incubated for 45 min in the dark at 37∘C. Following incubation, ROS
label was removed, and 100 μl of 1×PBS was added to each well. Fluorescence was
measured immediately at Ex/Em= 495/529 nm using a Synergy 2 Multi-Detection
Microplate Reader (BioTek Instruments, Inc., Winooski, VT, USA). Change in
fluorescence was determined after background subtraction.
Detection of antioxidant enzymes
The activity of glutathione peroxidase (GPx) was determined using a colorimetric
diagnostic assay kit purchased from BioVision Inc. (Milpitas, CA, USA), according to
the manufacturer’s protocols. Superoxide dismutase (SOD) was assessed using a
colorimetric activity kit from Invitrogen (Invitrogen, San Diego, CA, USA). Briefly, cells
were plated at a concentration of 2.5 x 105 cells/mL in a 6-well plate and allowed to
culture for 24 h before starting the experiment. Treatments were applied as described
previously. To prepare a cell pellet, the medium was removed, and 6-well plates were
rinsed with 1×PBS. Cells were harvested by gentle trypsinization, and 1 x 106 cells were
transferred to a microcentrifuge tube on ice. Microcentrifuge tubes were centrifuged at
250 × g for 10 min at 4°C, and the supernatant was discarded. The cell pellet was
resuspended in ice-cold 1×PBS and centrifuged at 250 x g for 10 min at 4°C. The
supernatant was discarded.
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For the SOD assay, 0.5 mL of 1xPBS were added to the cell pellet, and the
solution was transferred to a 2-mL RNase-free O-ring tube, containing one stainless steel
bead, 5 mm (Qiagen, Hilden, Germany) and homogenized in a Beadbeater (BioSpec
Products, Bartlesville, OK, USA) for 30s. After homogenization, the lysate was
transferred to a 2-mL microtube and centrifuged at 1,500 × g for 10 min at 4°C. The
supernatant was collected, and cell lysate was diluted at 1:3 with Assay Buffer. Samples
were stored at -80∘C until analysis. The assay was performed as described by the
manufacturer, with SOD standards and diluted samples plated in triplicate in a 96-well
plate. Absorbance was read at 450 nm using a spectrophotometer (Varian Cary 50 UVvis).
For the GPx assay, 0.2 mL of assay buffer were added to the cell pellet and this
solution was transferred to a 2-mL RNase-free O-ring tube, containing one stainless steel
bead, 5 mm (Qiagen, Hilden, Germany) and homogenized in a Beadbeater (BioSpec
Products, Bartlesville, OK, USA) for 30s. After homogenization, the lysate was
transferred to a 2-mL microtube and centrifuged at 10,000 × g for 15 min at 4°C. The
supernatant was collected, and samples were stored at -80∘C until analysis. The assay was
performed as described by the manufacturer, with a standard curve of NADPH and
samples in duplicate using a 96-well plate. The OD was measured at 340 nm at 0 and 30
min using a spectrophotometer (Varian Cary 50 UV-vis). The GPx activity is expressed
in nmol/min/mL or mU/m, and one unit is defined as the amount of enzyme that will
cause the oxidation of 1.0 µmol of NADPH to NADP+ under the assay kit condition per
minute at 25°C.
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Statistical analysis
Statistical analysis was conducted using the MIXED procedure of SAS 9.4 (SAS
Institute Cary NC, USA). Fixed effects were the treatments and run (as in replicate of
same analysis in different days), while replicate within each run was considered as a
random effect. Treatments were compared using orthogonal contrasts of (1) linear effect
of CA (0, 3, 6, and 9 mg/L stimulated with 500 µM H2O2), and (2) quadratic effect of CA
(0, 3, 6, and 9 mg/L stimulated with 500 µM H2O2). Data are shown as least squares
means ± standard error of the mean (SEM) for cell viability and intracellular ROS, while
GPx and SOD are displayed as fold change over culture medium control. Three replicate
cultures were completed for SOD and GPx, while four replicate cultures were completed
for intracellular ROS and Viability Assays. Significance was declared at p ≤ 0.05 and
tendencies as p ≤ 0.10.
Results and discussion
This study tested the hypothesis that CA would have a protective effect on
cultured cells subjected to hydrogen peroxide-induced oxidative damage. Results of cell
viability after 12 h of stimulation with CA followed by 12 h of induction of oxidative
damage are present in Figure 3.1A and Table 3.1. We observed a trend (p = 0.10) of a
treatment effect on viability. As expected, the control has the highest cell viability. In
comparison with control, hydrogen peroxide treatment reduced cell viability in all the
treatments, except for CA 9 mg/L, which did not differ from control (p = 0.30).
The effects of CA on cell viability have been reported by others, using different
cell lines, CA concentrations, and in vitro stressors. For example, Das et al. (2018)
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observed a CA dose-dependent (1-4 µM) increase in cell viability in arsenic-induced
toxicity of murine hepatocytes via the reduction of oxidative stress, MAPK activation,
and programmed cell apoptosis. In addition, a study by Costa et al. (2007), using greater
levels of CA (10, 20, and 30 µM), also showed a dose-dependent cytoprotective effect of
CA when hepatocytes were exposed to aflatoxin B1, which was evident by the greater
cell viability after 24 h of toxicity exposure. The authors attributed this effect to the
reduction of intracellular ROS and DNA oxidation within the cell.
In contrast, CA has also been correlated with decreased cell viability in other
studies. At concentrations of 70 µM, CA reduced hepatocyte (Hep G2 cells) viability to
around 70% (Costa et al., 2007), while a 10 µM concentration was enough to inhibit the
viability of AML12 cells as reported by Wang and Takikawa (2016). In the present study,
the concentrations of CA applied were around 9, 18, and 27 µM for the 3, 6, and 9 mg/L
treatments, respectively. At those concentrations, CA-treated cells exhibited cell viability
similar to the oxidative damage positive control (500 µM H2O2). However, at 9 mg/L,
CA increased the viability enough to be similar to the control treatment, suggesting a
level of cytoprotective effect at this concentration for AML12 cells subjected to hydrogen
peroxide-induced oxidative damage in vitro.
Results of intracellular ROS production after 12 h of stimulation with CA
followed by 12 h of induction of oxidative damage are present in Figure 3.1B and Table
3.1. Contrary to our initial hypothesis and its reported properties as a ROS scavenger, CA
treatment did not affect intracellular ROS production when AML12 cells were incubated
with 500 µM H2O2, used to simulate oxidative damage in vitro. In contrast to our study,
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Wang and Takikawa (2016) observed an inhibition in ROS production when hepatocytes
were subjected to 3 mM of H2O2 in the presence of 1 μM of CA. According to these
authors, CA likely protects against H2O2-induced liver damage by upregulation of SIRT1.
The upregulation of SIRT1 expression by CA has also been reported by Teng et al.
(2019), which observed an inhibition of neuronal apoptosis, and by Hu et al. (2015), who
found a protective effect of CA against hydrogen peroxide-induced oxidative injury in
hepatocytes. Since the SIRT1 signaling pathway is associated with the expression of
antioxidants (e.g., catalase and SOD) via the FoxO pathways (Salminen et al., 2013),
those results indicate that, other than being a direct ROS scavenger, CA affects oxidative
status through activation of antioxidant pathways. In terms of the absence of protective
effects of CA on ROS production in the present study, it should be considered that the
H2O2 levels used were 6 times lower than those reported by Wang and Takikawa (2016)
and Hu et al. (2015), which lead us to hypothesize that oxidative damage in the present
study was not high enough to be influenced by the presence of CA. Moreover, the levels
of CA applied by these other authors were lower compared with the present study. Wang
and Takikawa (2016) used 1 μM CA, while Hu et al. (2015) used levels between 2.5 and
10 μM of CA, which suggest that the levels used in our study (9, 18, 27 µM for the 3, 6,
and 9 mg/L treatments, respectively) might be excessive to promote a desirable
physiological protection against H2O2.
The activity of the antioxidant enzymes SOD and GPx after 12 h of stimulation
with CA followed by 12 h of induction of oxidative damage are present in Figure 3.2A
and B, respectively, and Table 3.1. Glutathione peroxidase is a selenium-dependent
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enzyme that catalyzes the degradation of hydrogen peroxide and organic peroxides to less
reactive water and alcohols, while the different types of superoxide dismutases are
copper, zinc, or manganese-containing enzymes that reduce superoxide anion (Sordillo
and Raphael, 2013).
No effect of treatments on GPx activity in AML12 cells was observed. In
contrast, we observed a treatment effect (p = 0.03) on SOD activity, in which CA
treatments at 6 and 9 mg/L presented greater SOD activity when compared to Control (p
<0.03). A linear (p < 0.01) increase in SOD activity was observed when CA
concentrations were increased from 0 to 9 mg/L. In contrast to our study, CA at 25 and
50 µM levels have been reported to increase GPx activity in lipid hydroperoxidemediated oxidative stress in colorectal cells (Caco-2 Cells), while SOD activation was
only observed when levels of CA reached 100 µM (Wijeratne and Cuppett, 2007).
Moreover, Sahu et al. (2011) showed that CA at 100 mg/kg of BW enhanced the
activities of GPx and SOD in rat kidneys exposed to toxic doses of cisplatin. Similarly,
Xiang et al. (2013) reported that CA supplementation at 15, 30, and 60 mg/kg of BW
markedly enhanced the cellular antioxidant defense system (e.g., superoxide dismutase,
glutathione peroxidase, and glutathione) in serum and liver of rats after LPS challenge.
The positive effects of CA on the antioxidant mechanism might be attributed to its
role in the activation of the PI3K/Akt/NRF2 signaling pathway (de Oliveira et al., 2015;
de Oliveira et al., 2016) and through the SIRT1 pathway, as discussed previously.
Nuclear factor erythroid-2 related factor 2 (NRF2) is a transcription factor involved in the
cellular response to oxidative stress, inducing the expression of several protective
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enzymes, such as glutathione peroxidase and superoxide dismutase (de Oliveira et al.,
2016). Although in the conditions of the present study CA did not affect GPx activity, a
dose-dependent effect on SOD activity might indicate an increase in the overall
antioxidant capacity of AML12 subjected to hydrogen peroxide-induced oxidative cell
damage.
Conclusions
The findings of the present study revealed that carnosic acid promotes positive
effects on viability and antioxidant capacity through superoxide dismutase activity in
mouse hepatocytes subjected to hydrogen peroxide-induced oxidative cell damage in
vitro. Results from this study indicate that carnosic acid supplementation might be
beneficial during periods of redox balance alterations in vivo, although further studies are
necessary to determine dose-dependent responses and safety levels. In addition, future
studies should address the effects of CA on NEFA-induced ROS production in bovine
hepatocytes to simulate the oxidate stress damage caused to the liver during the transition
period of dairy cows.
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Table 3.1. Effect of carnosic acid (CA) on H2O2-induced AML12 cells on viability, intracellular ROS production, superoxide
dismutase (SOD) and glutathione peroxidase (GPx) activities.

Parameter

p-Value
Treatments
500 µM H2O2 + CA
SEM1
Trt5 Linear6 Quadratic7
3 mg/L 6 mg/L
9 mg/L
4376.1b 4529.2b 4813.4ab 225.5 0.10 0.20
0.46
a
a
a
10.08
10.17
11.25
0.92 0.02 0.13
0.89
1.13bc
1.38ab
1.56a
0.13 0.03 <0.01
0.64
1.40
1.19
1.01
0.31 0.81 0.80
0.36

Control 0 mg/L
Viability2
5149.0a 4429.1b
Intracellular ROS3 6.92b
9.25ab
SOD activity4
1.00c
1.05bc
GPx activity4
1.00
1.05
1
Largest standard error of the mean is shown.
2
Luminescence measurement.
3
Relative fluorescence units (RFU).
4
Fold change over control.
5
p value for the comparison between all treatments.
6
p value for the linear effect of CA (0, 3, 6, and 9 mg/L stimulated with 500 µM H2O2).
7
p value for the quadratic effect of CA (0, 3, 6, and 9 mg/L stimulated with 500 µM H2O2).
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Figure 3.1. Effect of carnosic acid (CA) on H2O2-induced AML12 cells on Viability (A)
and Intracellular ROS production (B). AML12 cells were pretreated with different
concentrations of CA (3.0, 6.0 and 9.0 mg/L) for 12 h. Means with different letters (a–b)
differ (p < 0.05). Four replications were done for each experiment. Values are means, with
SEM represented by vertical error bars.
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Figure 3.2. Effect of carnosic acid (CA) on H2O2-induced AML12 cells on Superoxide
Dismutase (SOD) (A) and Glutathione Peroxidase (GPx) (B) activities. AML12 cells were
pretreated with different concentrations of CA (3.0, 6.0 and 9.0 mg/L) for 12 h, and then
treated with 500 µM H2O2 for 12 h. Means with different letters (a–c) differ (p < 0.05).
Four replications were done for each experiment. Values are means, with SEM represented
by vertical error bars.
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CHAPTER 4. OVERALL DISCUSSION

The many challenges faced by transition dairy cows have been a topic of
discussion and research for the last few decades. Although different strategies have been
applied to reduce the severity and incidence of health disorders around parturition, this
period remains the most critical in the dairy cow’s life. Oxidative stress, an underlying
factor for dysfunctional immune response and inflammation, has been studied as a key
factor in the search for a better transition from pregnancy to lactation in high-yielding
dairy cows. Most recently, natural compounds with antioxidant properties have been
investigated as alternatives to commercial antioxidants (e.g., vitamins and minerals).
In this context, we proposed the use of carnosic acid, a phenolic diterpene found
in plants of the Lamiaceae family, such as rosemary, known for its antioxidants, antiinflammatory, and antimicrobial properties. To our knowledge, this is the first experiment
to evaluate the effects of carnosic acid in transition dairy cows. Positive effects of
carnosic acid infusion in the in vivo study regarding milk production and biomarkers of
inflammation and oxidative stress led us to further investigate this natural compound in
an in vitro study. The in vitro study, using mouse hepatocytes under oxidative stress
conditions, showed interesting results as carnosic acid increased cell viability and
superoxide dismutase activity under the experimental conditions, further proving its
protective and antioxidant properties.
Although both in vivo and in vitro studies showed promising results, these
experiments present some limitations. There are missing pieces of information as we
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cannot yet determine the exact mechanism in which carnosic acid acts in the context of
the transition cow metabolism. In the in vivo study, there was a limitation of low number
of experimental animals. In addition, no differences were observed among treatments
based on important oxidative stress blood biomarkers such as ROS, antioxidant capacity
(e.g., ORAC and FRAP), and ratios between oxidants and antioxidant defenses (e.g.,
ROM/FRAP and ROM/ORAC). For the in vitro study, contrary to our hypothesis,
carnosic acid neither reduced ROS concentration nor increased glutathione peroxidase
activity in mouse hepatocytes under the proposed carnosic acid dosages and oxidative
stress conditions.
As future perspectives for the use of carnosic acid or its plant-based source
rosemary to transition dairy cows, future research should address a) how carnosic acid is
metabolized in ruminants, b) estimate optimal dosages of supplementation, and c) which
mechanisms might affect immune cells and hepatic metabolism of transition dairy cows.
As an example of a possible follow-up study, different levels of rosemary leaves
could be supplemented from -21 to 21 days relative to calving to evaluate its effects on
the antioxidant capacity and inflammatory status of transition cows following parturition.
Concentrations of carnosic acid and other rosemary phenols could be determined in
blood, milk, and peripheral tissues following supplementations to further understand its
pharmacokinetics and metabolism. The effects of dietary rosemary leaves or extracts in
the rumen microbiota and environment could also be addressed. In addition, liver tissue
and PMNL gene expression during the period of supplementation might help to
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determine the mechanism by which carnosic acid might have positive effects on milk
production, redox balance, and inflammatory status, as observed in our in vivo study.
An important aspect to be considered when supplementing carnosic acid or its
plant-based sources to dairy cows is the possible alternations in the milk. Increased
concentration of carnosic acid in milk of goats supplemented with rosemary leaves was
reported by Jordan et al. (2010). Moreover, these authors also observed an increase in
plasma concentrations of carnosic acid of the suckling kids from supplemented goats.
Results from this previous study raise questions regarding how carnosic acid
supplementation in dairy cows might a) alter milk organoleptic properties, b) affect milk
shelf life, and c) impact absorption and contribute to beneficial effects in humans.
Overall, the present studies show potential benefits of providing antioxidants such
as carnosic acid to transition dairy cows in terms of milk production and blood
biomarkers related to inflammation and oxidative stress. Based on our in vitro study, we
observed that carnosic acid positively affected the antioxidant capacity of hepatocytes
under oxidative damage conditions, which is a promising aspect considering the liver as a
central organ during the peripartal period.
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